Sommaire

Numéro précédent | Numéro suivant

• • ·Editorial board

    Page :iii-iii

    

• 5 April 2008 CME Course: Suicide and risk management in depressed pediatric patients

  • ·CME course: Suicide and risk management in depressed pediatric patients

    Page :1-1

    G. Zalsman, S. Tyano, F. Resch

    

• 6 April 2008 Core Symposium: Integrated treatment of sexual dysfunctions

  • ·Integrated treatment of male and female desire disorders

    Page :1-1

    R.T. Segraves, K.B. Segraves

    
  • ·Integrated treatment of female and male sexual arousal disorders

    Page :1-2

    R. Balon

    Résumé Résumé Plan Plan

• 6 April 2008 Core Symposium: Integrated treatment of sexual dysfunctions

  • ·Integrated treatment of female and male orgasmic disorders

    Page :2-2

    M.D. Waldinger

    

• Symposium: Animal models of CNS disorders. Effects of drug treatments

  • ·Gene-environment interaction in an animal model of depression

    Page :2-2

    A.A. Mathé, A. El Khoury, S.H. Gruber

    

• Symposium: Animal models of cns disorders. effects of drug treatments

  • ·High and low anxiety rat model: Emotionality, neuropeptides and aggression

    Page :2-2

    I.D. Neumann

    
  • ·The nitric oxide pathway in anxiety and stress-related disorders

    Page :2-3

    G. Wegener, V. Volke, B.H. Harvey

    Résumé Résumé Plan Plan

• Symposium: Quality of care in emergency psychiatry: New perspectives

  • ·Therapeutic alliance in emergency psychiatry: A newly validated questionnaire

    Page :3-3

    C. Damsa, E. Adam, A. Mihai, E. Clivaz, S. Maris, T. Perneger

    
  • ·Specific staff educational crisis intervention for the management of violent behaviour in emergency - The interest of a follow-up study?

    Page :3-3

    A. Mihai, L. Caihol, E. Adam, I. Gollard, C. Damsa

    
  • ·The impact of a specific diagnosis and intervention program for managing patients with suicidal thoughts and behaviour

    Page :3-4

    E. Adam, A. Mihai, S. Welker, L. Cailhol, C. Damsa, F. Sarasin

    Résumé Résumé Plan Plan

• Symposium: Quality of care in emergency psychiatry: New perspectives

  • ·Quality of care in emergency psychiatry: Developing an international network

    Page :4-4

    C. Lazignac, C. Damsa, E. Adam, A. Mihai, L. Caihol, D. Stamatoiu, M.H. Allen

    

• Symposium: Pathways to care and the immigrant patient: Ethical perspectives from cultural psychiatry

  • ·Access to mental health care: How can barriers for migrants be reduced?

    Page :4-4

    C. Haasen, A. Agorastos, C. Demiralay, J. Reimer

    
  • ·Ethical dilemmas in assessment and treatment of asylum seekers in Denmark

    Page :4-4

    D. Mucic

    
  • ·Racism is an ethical issue

    Page :4-5

    A. Qureshi, F. Collazos, H.W. Revollo, M. Ramos

    Résumé Résumé Plan Plan

• Symposium: Suicide, an unexpected event for health professionals: Focus on prevention

  • ·Suicide, an unexpected event for health professionals

    Page :5-5

    R. Tatarelli

    
  • ·Communication of suicide intent, fact or myth?

    Page :5-5

    M. Pompili

    
  • ·Dealing with suicidal patients

    Page :5-5

    Z. Rihmer

    
  • ·Is education enough for preventing suicide? the Gotland study and beyond

    Page :5-6

    W. Rutz

    Résumé Résumé Plan Plan

• Symposium: Suicide, an unexpected event for health professionals: Focus on prevention

  • ·Substance abuse and suicide risk in schizophrenia

    Page :6-6

    P. Girardi, M. Pompili

    

• Joint AEP/ECNP: Psychopharmacological intervention in major psychiatric disorders

  • ·Strengths and weaknesses of evidence-based medicine (EBM)

    Page :6-6

    M. Davidson

    
  • ·Lessons from the long term bipolar study, balance

    Page :6-6

    G. Goodwin

    Plan Plan
  • ·Lessons from schizophrenia study: Eufest

    Page :6-7

    R.S. Kahn, W.W. Fleischhacker

    Résumé Résumé Plan Plan

• Symposium: The consequences of insomnia

  • ·A comparison of insomnia and depression in disability pension award

    Page :7-7

    S. Overland

    
  • ·Sleep disturbances and duration of sleep as risk-factors for mortality

    Page :7-7

    D. Neckelmann, O. Bjerkeset, B. Sivertsen, S. Overland, A. Mykletun

    
  • ·The effect of short sleep duration on ongoing psychiatric morbidity

    Page :7-7

    N. Glozier, R. Ivers, A. Martiniuk, M. Stevenson

    
  • ·The effect of insomnia and sleep duration on work disability

    Page :7-8

    B. Sivertsen, S. Overland, D. Neckelmann, A. Mykletun

    Résumé Résumé Plan Plan

• Symposium: Addiction and psychiatric comorbidity: Rule or exception?

  • ·Cannabis and psychosis

    Page :8-8

    I.B. Crome

    
  • ·Cocaine addiction and psychotic disorders

    Page :8-8

    E.J. Franzek, I.C. Elsenaar

    
  • ·Addiction and add

    Page :8-8

    B.J.M. van de Wetering

    
  • ·The link between PTSD and substance misuse

    Page :8-9

    L.M. Najavits

    Résumé Résumé Plan Plan

• Symposium: Recent advances in the understanding of adolescent conduct disorder

  • ·Emotional processing in conduct disorder: Data from psychophysiology and neuroimaging

    Page :9-9

    S. Herpetz

    

• Symposium: Vulnerability factors in depression across the life span

  • ·Genetic determinants of neurobiological vulnerability markers in depression

    Page :9-9

    M. Ising, S. Adena, E. Binder, A. Pfennig, M. Schalling, B. Mueller-Myhsok, S. Modell, F. Holsboer

    
  • ·Author index

    Page :1-21

    Résumé Résumé Plan Plan
  • ·Psychological vulnerability factors and neuroendocrine and sleep regulation in healthy children and adolescents

    Page :9-10

    S. Brand, J. Beck, F. Muheim, M. Hatzinger, E. Holsboer-Trachsler

    Résumé Résumé Plan Plan

• Symposium: Vulnerability factors in depression across the life span

  • ·Sleep regulation and cognitive performance in elderly subjects with dementia and depression

    Page :10-10

    U. Hemmeter, R. Rocamora, A. Thum, A. Haag, M. Hatzinger, W. Cassel, C.J. Krieg, E. Holsboer-Trachsler

    
  • ·Neuroendocrine and sleep regulation as predictors of illness course and therapy in depression

    Page :10-10

    M. Hatzinger, S. Brand, U. Hemmeter, M. Ising, E. Holsboer-Trachsler

    

• Plenary Lecture: Pathways to integrative care in childhood

  • ·Pathways to integrative care in childhood

    Page :10-10

    S. Kutcher

    
  • ·Physical illness and access to medical services in people with schizophrenia

    Page :10-11

    M. Maj

    Résumé Résumé Plan Plan

• Satellite Symposium: Realizing the potential of new antipsychotics: Practical advice for optimizing schizophrenia care. Sponsored by Bristol Myers Squibb

  • ·The art and science of switching in patients with schizophrenia: Strategies for achieving a smooth transition

    Page :11-11

    A. Fagiolini

    

• Satellite Symposium: Realizing the potential of new antipsychotics: Practical advice for optimizing schizophrenia care. Sponsored by bristol myers squibb

  • ·Shifting schizophrenia treatment paradigms: The scope for adjunctive therapies

    Page :11-11

    D.J. Nutt

    
  • ·Meeting the need for efficacy without over-sedation in patients with schizophrenia

    Page :11-12

    S. Kasper

    Résumé Résumé Plan Plan

• Core Symposium: Combined psychopharmacotherapy and psychotherapy

  • ·Combination of antidepressants and cognitive behaviour therapy

    Page :12-12

    H.J. Moeller

    
  • ·Psychological treatments combined with drug therapy in bipolar disorder

    Page :12-12

    E.S. Paykel

    
  • ·The relevance of psychoeducation in the treatment of schizophrenia

    Page :12-13

    J. Baeuml, G. Pitschel-Walz

    Résumé Résumé Plan Plan

• CME Course: Networking as a strategy in psychiatry

  • ·Social network strategies for leading

    Page :13-13

    M. Ventresca

    

• Symposium: The WPA presidential global child mental health program

  • ·The WPA presidential global child mental health program; An overview

    Page :13-13

    T. Okasha

    

• Symposium: The wpa presidential global child mental health program

  • ·Preventive interventions in child and adolescent psychiatry with special reference to school drop-out

    Page :13-13

    H. Remschmidt

    
  • ·Is there a link between slow learning, school failure and delinquency?

    Page :13-14

    P.A. Rydelius

    Résumé Résumé Plan Plan

• Symposium: The WPA presidential global child mental health program

  • ·Suicide prevention in youth

    Page :14-14

    D. Wasserman

    

• Symposium: Future diagnostic trends in personality disorders

  • ·Towards DSM-V personality disorder diagnoses: Moving from the dimensional-vs-categorial controversy to the useful-vs-unuseful perspective

    Page :14-14

    A. Fossati

    
  • ·Violence among severely mentally ill patients in general psychiatric services

    Page :14-15

    S. Hodgins

    Résumé Résumé Plan Plan

• Symposium: General psychiatric patients who need reinstitutionalisation in forensic facilities

  • ·From general to forensic psychiatry and back

    Page :15-15

    R. Mueller-Isberner

    
  • ·Re-institutionalisation of the severely mentally ill - who or what is to blame?

    Page :15-15

    H. Schanda

    

• Symposium: Delirium in the elderly

  • ·Risk factors for delirium in the elderly after coronary artery bypass(CABG)

    Page :15-15

    J.W. Leszek

    
  • ·Delirium and suicidal behaviour in the elderly

    Page :15-16

    K.G. Paplos, V.P. Kontaxakis

    Résumé Résumé Plan Plan

• Symposium: Treatment of cocaine dependence : The state of the science

  • ·Neurobiology and treatment of cocaine dependence

    Page :16-16

    D.A. Gorelick

    
  • ·A Pet imaging study of the effects of modafinil and topiramate on brain mechanisms underlying cue-induced cocaine craving and dependence in cocaine-dependent and methadone maintained cocaine-dependent patients

    Page :16-16

    A. Weinstein, L. Karila, M. Sanchez, W. Lowenstein, G. Lambert, I. Herman, N. Freedman, R. Mishani, H. Atlan, R. Chisin

    
  • ·Cocaine rapid evaluation screening trials: Design, results, and lessons learned

    Page :16-17

    F. Vocci

    Résumé Résumé Plan Plan

• Symposium: Treatment of cocaine dependence : The state of the science

  • ·Behavioural therapies for the treatment of cocaine dependence

    Page :17-17

    L. Karila, A. Weinstein, A. Benyamina

    

• Symposium: Hallucination in children and adolescents: Risk factors and treatment strategies

  • ·Coupling repetitive TMS with functional MRI for the treatment of drug-resistant hallucinations in children with early onset schizophrenia

    Page :17-17

    R. Jardri, Y. Delevoye-Turrell, B. Lucas, D. Pins, P. Thomas, P. Delion, J.L. Goeb

    
  • ·The effectiveness of hallucination focused integrative treatment

    Page :17-17

    J.A. Jenner, G. van de Willige

    
  • ·Prevalence and correlates of psychotic-like experiences and other putative antecedents of schizophrenia in children aged 9-12 years

    Page :17-18

    K.R. Laurens, S.A. West, E.A. Taylor, R.M. Murray, S. Hodgins

    Résumé Résumé Plan Plan

• Symposium: Hallucination in children and adolescents: Risk factors and treatment strategies

  • ·Does the environment increase sensitivity to develop psychosis in young adolescents?

    Page :18-18

    T. Lataster, E. De Loore, M. Drukker, N. Gunther, F. Feron, D. Deboute, C. Henquet, J. Van Os, I. Myin-Germeys

    

• Symposium: Genomic imaging – affect and psychoses

  • ·A Neuregulin 1 variant associated with altered brain structure and function

    Page :18-18

    A.M. McIntosh

    
  • ·Genotype effects on central processing of affective stimuli

    Page :18-19

    A. Heinz, F. Friedel, I. Puls, J. Wrase, J. Gallinat

    Résumé Résumé Plan Plan

• Symposium: Genomic imaging – affect and psychoses

  • ·Influences of snap-25 polymorphisms on cognition and MRS spectra in psychoses and OCD

    Page :19-19

    P. Falkai, H. Scherk, M. Backens, T. Schneider-Axmann, T. Wobrock, W. Reith, H.J. Möller, B. Bondy, O. Gruber

    

• Symposium: Migrant women - An issue of importance for European psychiatrists

  • ·Migrant women and their utilization of psychiatric serives compared to Danish women

    Page :19-19

    M.C. Kastrup, K. Helweg-Larsen

    

• Symposium: Migrant women - An issue of importance for european psychiatrists

  • ·Mental health issues of turkish female immigrants residing in the UK - A follow-up study

    Page :19-19

    D. Kohen

    
  • ·Symposium in migrant women:war rape disclosure in women refugee

    Page :19-20

    C.B. Bonnet

    Résumé Résumé Plan Plan

• Symposium: Migrant women - an issue of importance for european psychiatrists

  • ·Psychiatric and social consequences of migration of Romanian women

    Page :20-20

    I.V. Miclutia, C.A. Popescu

    

• Symposium: Assessment and treatment of sexual and violent offenders

  • ·Community treatment of sexual offenders

    Page :20-20

    P. Cosyns

    
  • ·Childhood abuse in a sample of Swiss violent offenders

    Page :20-20

    A. Rossegger

    
  • ·Pharmacotherapy of sexual ofenders

    Page :20-21

    P. Briken

    Résumé Résumé Plan Plan

• Symposium: Assessment and treatment of sexual and violent offenders

  • ·Prison misconduct: The role of risk assessment instruments in the prediction of intramural violence

    Page :21-21

    J. Endrass

    

• Symposium: Alcoholism and substance misuse in psychiatric emergency

  • ·Suicide, self harm and substance misuse in young people

    Page :21-21

    I.B. Crome, R. Bloor, M. Frisher

    
  • ·Treatment of alcohol withdrawal with delirium in emergency room - Romanian experience

    Page :21-21

    A. Mihai, A. Racz, C. Suciu, A. Nirestean

    
  • ·Treatment guidelines of agitation due to substance intoxication in emergency

    Page :21-22

    C. Damsa, A. Coman, C. Lazignac, A. Mihai

    Résumé Résumé Plan Plan

• Symposium: Alcoholism and substance misuse in psychiatric emergency

  • ·Personality disorders and alcohol abuse in emergency setting

    Page :22-22

    A. Nirestean, J. Laszlo, A. Mihai

    

• Symposium: Eating disorders

  • ·Eating habits and eating related psychopathology in patients prior to bariatric surgery and at a 1 year follow up

    Page :22-22

    B. Muehlhans, T. Horbach, M. de Zwaan

    
  • ·Imaging serotonergic and dopaminergic neurocircuits in eating disorders: New insight into behavior and treatment

    Page :22-22

    U.F. Bailer, G.K. Frank, J.C. Price, C.C. Meltzer, C.A. Mathis, A. Wagner, W.H. Kaye

    
  • ·Technology-based interventions for young people with bulimia nervosa and related disorders

    Page :22-23

    U.H. Schmidt

    Résumé Résumé Plan Plan

• Symposium: International collaboration between developing and developed countries in psychiatry

  • ·International collaboration in psychiatry: Perils and gains

    Page :23-23

    N. Sartorius

    
  • ·Teaching ethics and medical conduct in developing countries under unstable political conditions

    Page :23-23

    O. Steenfeldt Foss

    
  • ·Access to antipsychotics for schizophrenic patients in developing countries

    Page :23-23

    D. Moussaoui, D.A. Gerard

    
  • ·Disability in mental disorders - diagnostic criterion on separate axis

    Page :23-24

    W. Rössler

    Résumé Résumé Plan Plan
  • ·Assessing disability – methodological issues

    Page :24-24

    D. Wiersma

    
  • ·Disability and clinical course of severe mental illness

    Page :24-24

    M. Ruggeri, A. Lasalvia, K. De Santi, D. Cristofalo, C. Bonetto

    
  • ·Daly's - a concept useful in mental health care?

    Page :24-24

    R. Kilian

    
  • ·Integrative approaches to treatment: Ethical issues arising in the care for children

    Page :24-25

    P. Graham

    Résumé Résumé Plan Plan
  • ·Collaboration between industrialized and developing countries in psychiatry

    Page :25-25

    D. Moussaoui

    
  • ·Ethical questions in integrating standard therapies and alternative therapies in psychiatry

    Page :25-25

    H. Helmchen

    
  • ·Attention deficit/hyperactivity disorder and dyslexia: evidence for shared genetic susceptibility

    Page :25-26

    C.L. Barr, K. Wigg, N. Laurin, V. Misener, T. Cate-Carter, L.W. Maureen, E. Kerr, J. Couto

    Résumé Résumé Plan Plan
  • ·Adult ADHD and the Circadian rhythm

    Page :26-26

    J.J.S. Kooij, M.M. Van Veen, A.M. Boonstra

    Plan Plan
  • ·The prevalence of ADHD in adults with bipolar II disorder

    Page :26-26

    M.B.J. Blom

    
  • ·ADHD frequency and characteristics in students suffering from learning disabilities

    Page :26-27

    I. Manor, S. Medad, Z. Zamishlani, N. Vurmbrand

    Résumé Résumé Plan Plan
  • ·Cognitive endophenotypes: Why are we still trying to find them?

    Page :27-27

    A. Szoke, F. Schurhoff, M. Leboyer

    
  • ·Do putative endophenotypes go together? The case of schizotypy dimensions and neurocognitive domains

    Page :27-28

    N. Barrantes-Vidal, M. Fatjo-Vilas, M. Aguilera, S. Miret, S. Campanera, M.E. Navarro, M.J. Munoz, L. Fananas

    Résumé Résumé Plan Plan
  • ·Specific neurocognitive deficits are related to inferred genetic risk in unaffected parents of schizophrenic patients

    Page :28-28

    M. Wagner, S. Schulze-Rauschenbach, R. Pukrop, S. Ruhrmann, J. Klosterkoetter, W. Maier

    
  • ·Genetic and neuroimaging studies of antisaccade eye movements in schizophrenia

    Page :28-28

    U. Ettinger

    
  • ·Sensitization to stress: An endophenotype for psychosis

    Page :28-28

    I. Myin-Germeys, M. Lardinois, T. Lataster, R. Mengelers, J. van Os

    
  • ·Epidemiology of substance misuse, psychiatric comorbidity and gender

    Page :28-29

    I.B. Crome

    Résumé Résumé Plan Plan

• April 2008 Symposium: Drug dependence and gender

  • ·Aetiology of gender effects and dependence

    Page :29-29

    U. Havemann-Reinecke

    
  • ·Gender aspects in the development and treatment of dependence

    Page :29-29

    A. Heinz, J. Wrase

    
  • ·Substance dependence and pregnancy

    Page :29-29

    N. Ebner, G. Fischer

    
  • ·The clinical meaning of nonverbal behavior during psychiatric interviews

    Page :29-30

    A. Troisi

    Résumé Résumé Plan Plan

• Symposium: Nonverbal behaviour in psychiatric populations

  • ·Kinematic analysis of facial expression behaviour in psychiatric patients

    Page :30-30

    G. Juckel, C. Cave

    
  • ·Poor nonverbal communication, negative interpersonal events, and recurrence of depression

    Page :30-30

    E. Geerts, T.W.D.P. Van Os

    
  • ·Non-verbal behaviour and social cognition in schizophrenia spectrum disorders

    Page :30-30

    M. Bruene

    
  • ·Psychopathology and classification: Married or divorced

    Page :30-31

    M. Musalek

    Résumé Résumé Plan Plan

• Symposium: Psychopathology and classification - married or divorced?

  • ·Pychopathology and classification - married or divorced

    Page :31-31

    G. Stanghellini

    

• Symposium: Current issues on genetics of suicidal behaviour

  • ·Genetic findings in the HPA-axis in suicide attempters

    Page :31-31

    D. Wasserman, M. Sockolowski, J. Wasserman

    
  • ·Role of BDNF gene in suicidal behaviours

    Page :31-31

    M. Sarchiapone

    
  • ·Role of serotonergic pathways on suicidal behaviour: Relationship with the impulsivity of the suicide attempt

    Page :31-32

    P. Saiz

    Résumé Résumé Plan Plan

• Symposium: Current issues on genetics of suicidal behaviour

  • ·Interplay of environment, genes and cognitions in the vulnerability to suicide attempts

    Page :32-32

    P. Courtet

    

• Symposium: Predictors of the longitudinal course of mood and anxiety diosorders

  • ·Predictors of the longitudinal course of mood and anxiety disorders in children and adolescents

    Page :32-32

    M. Preisig, S. Rothen, O. Halfon, D. Fornerod, C.L. Vandeleur, F. Ferrero

    
  • ·Childhood adversity as a risk factor for the early onset and chronicity of depression and anxiety disorders

    Page :32-32

    J. Angst, A. Gamma, V. Ajdacic-Gross, W. Roessler

    
  • ·Predictors of the longitudinal course of depression and quality of life in depressed patients

    Page :32-33

    C.H. Kuehner, S. Huffziger

    Résumé Résumé Plan Plan

• Symposium: Predictors of the longitudinal course of mood and anxiety diosorders

  • ·Recurrent depression: An overview

    Page :33-33

    F. Hardeveld, J. Spijker, R. de Graaf, W.A. Nolen, A.T.F. Beekman

    

• YP Symposium: Job satisfaction and job profiles of young psychiatrists in Europe

  • ·Train the trainee to be a trainer: How to survive the transition from residency to responsibility

    Page :33-33

    V.J.A. Buwalda

    

• YP Symposium: Job satisfaction and job profiles of young psychiatrists in europe

  • ·Burn-out in young psychiatrists: A specific risk?

    Page :33-33

    U. Volpe

    
  • ·Doing research in the USA: Chances and challenges for young European psychiatrists

    Page :33-34

    T.G. Schulze

    Résumé Résumé Plan Plan

• Plenary lecture: Pathways to integrative care in adults

  • ·Pathways to integrated care: Adults

    Page :34-34

    N. Sartorius

    

• Satellite Symposium: A vision of future treatment paradigms in bipolar mania: The promise of new antipsychotics. Sponsored by Bristol Myers Squibb

  • ·Current treatment paradigms in bipolar mania: The European landscape

    Page :34-34

    F. Bellivier

    
  • ·Introducing Aripiprazole: Clinical evidence in the acute and long-term settings in bipolar mania

    Page :34-34

    E. Vieta

    
  • ·From study to practice in bipolar mania: Recommendations for optimizing the clinical benefits of new antipsychotics

    Page :34-35

    A. Fagiolini

    Résumé Résumé Plan Plan

• Core Symposium: Development of classifications of mental disorders

  • ·Progress towards the development of the DSM-V

    Page :35-35

    D.A. Regier

    
  • ·Ensuring contributions to the revision of the classifications from the world scientific community: Example of German speaking countries

    Page :35-35

    W. Gaebel

    
  • ·Participation of users of psychiatric services in the classification of mental disorders

    Page :35-35

    D. Rose

    
  • ·Images of mental illness in central Asia: Casebooks as educational tools

    Page :35-36

    J. Cooper, N. Sartorius

    Résumé Résumé Plan Plan

• Core Symposium: Integrated approach for the treatment of neuropsychiatric symptoms in the elderly

  • ·How to rate depression and apathy in dementia and in non demented elderly: The VA experience

    Page :36-36

    J. Yessavage

    
  • ·Integrated understanding of neuropsychiatric symptoms: From clinical trials to real life

    Page :36-36

    P.H. Robert, M. Benoit, S. Gonfrier, S. Andrieu

    
  • ·Informal caregiving in Dementia: Results of a survey

    Page :36-37

    C.A.G. Wolfs, F.R.J. Verhey, C.D. Dirksen, A. Kessels, J.L. Severens

    Résumé Résumé Plan Plan

• Core Symposium: Integrated approach for the treatment of neuropsychiatric symptoms in the elderly

  • ·Neuropsychiatric Symptoms (BPSD) in severe dementia

    Page :37-37

    E.J. Byrne

    

• Symposium: Clinical and epidemiological perspectives of work-related disability in mental illness

  • ·Employment in neurological disorders: The role of psychiatric comorbidity

    Page :37-37

    N. Glozier

    
  • ·Health status before, during and after disability pension award

    Page :37-37

    S. Overland

    
  • ·Symptoms of anxiety and depression predict report of whiplash trauma

    Page :37-38

    A. Mykletun, N. Glozier, M. Henderson, S. Overland, H.G. Wenzel, S. Wessely, M. Hotopf

    Résumé Résumé Plan Plan

• Symposium: Recent findings in alexithymia research

  • ·Alexithymia among finnish male prisoners

    Page :38-38

    A.K. Mattila, K. Hypen, N. Andersson, M. Samppala, M. Joukamaa

    
  • ·Familial transmission of alexithymia

    Page :38-38

    H.J. Grabe, J. Mahler, C. Spitzer, H.J. Freyberger

    Plan Plan
  • ·Does alexithymia predict non-response to psychotherapy?

    Page :38-39

    M. Rufer, R. Albrecht, J. Zaum, I. Hand, C. Mueller, O. Schmidt

    Résumé Résumé Plan Plan

• Symposium: Recent findings in alexithymia research

  • ·Cellular phone communication and alexithymia - results of the Radep study

    Page :39-39

    M. Joukamaa, S. Luutonen, R.K.R. Salokangas

    

• Symposium: Immunotherapy of neurodegenerative disorders

  • ·Human anti-prion protein antibodies block A117V PrP peptide fibril formation and prevent A117V PrP peptide-induced neurotoxicity

    Page :39-39

    X. Wei, Y. He, J. Tan, R. Dodel, H. Hampel, M. Farlow, Y. Du

    
  • ·Biological and Imaging markers as outcome measures for secondary prevention trials in Alzheimer's disease

    Page :39-40

    H. Hampel

    Résumé Résumé Plan Plan

• Symposium: Preventing depression

  • ·Prevention of depression: Possibilities and challenges

    Page :40-40

    P. Cuijpers

    
  • ·Temperament, personality and depressions: The case of the melancholic type

    Page :40-40

    G. Stanghellini

    
  • ·Preventive strategies for depression: Conceptual, methodological, and practical issues

    Page :40-40

    C.H. Kuehner

    
  • ·Neurobiology of alcoholism, an update

    Page :40-41

    A. Heinz

    Résumé Résumé Plan Plan

• Core Symposium: Alcoholism, from neurobiology to new treatment approaches

  • ·Alcoholism, new data on gene X environment interaction

    Page :41-41

    P. Gorwood, Y. LeStrat, M. Wohl, N. Ramoz

    
  • ·Mouse strain related effects of cannabinoid and serotonergic ligands on alcohol appetence

    Page :41-41

    L. Lanfumey, S. Kelai, M. Hamon

    
  • ·Which treatment for whom? Data from project predict

    Page :41-41

    K. Mann, F. Kiefer, M. Smolka, T. Lemenager

    

• Symposium: Is Kreapelins dichotomy of the endogenous psychoses still up-to-date?

  • ·The three-part-division of endogenous psychoses

    Page :42-42

    E.J. Franzek

    
  • ·Renaissance of unitary psychosis

    Page :42-42

    M. Musalek

    

• Symposium: The impact of migration on mental health and mental illness

  • ·The impact of migration on mental health and mental illness

    Page :42-42

    C. Hoschl, P. Ruiz, M. Casas, M. Musalek, W. Gaebel, L. Vavrusova

    Plan Plan

• Symposium: Altered white matter communication in schizophrenia and bipolar disorder: A possible common endophenotype?

  • ·Uncinate fasciculus and cingulum bundle findings in first episode schizophrenia and first episode bipolar disorder: A diffusion tensor imaging study

    Page :43-43

    M.E. Shenton, T. Kawashima, M. Nakamura, S. Bouix, D.F. Salisbury, C.F. Westin, R.W. McCarley, M. Kubicki

    
  • ·White matter volume in the schizophrenia and bipolar spectrum

    Page :43-43

    M.S. Buchsbaum, K. Rogers, M.M. Haznedar, E. Canfield, J. Entis, E. Hazlett, L. Siever

    
  • ·Evidence of shared white matter disruption in bipolar disorder and sschizophrenia

    Page :43-43

    A.M. McIntosh, J. Sussmann, G.K.S. Lymer, S. Munoz Maniega, M. Bastin, J. Hall, S. Lawrie, E. Johnstone, J. Clayden, D. Job, T.W.J. Moorhead

    
  • ·Cytoarchitecture alterations of white matter in schizophrenia and bipolar disorder

    Page :43-44

    P. Brambilla

    Résumé Résumé Plan Plan

• Symposium: Mental health outcome assessment and feedback: An international perspective

  • ·Attitudes of clinicians to routine outcome measurement in mental health

    Page :44-44

    T. Trauer

    
  • ·Effect of outcome monitoring and management in German inpatient psychiatric care: Cluster-randomised trial

    Page :44-44

    B. Puschner, D. Schöfer, C. Knaup, T. Becker

    
  • ·Interpretation of data for the regulatory agency, for the scientific community and for practicing psychiatrists

    Page :44-45

    P. Czobor

    Résumé Résumé Plan Plan

• Symposium: Pharmacological prevention of suicide

  • ·Lowering suicide rates: Realistic or Quixotic

    Page :45-45

    D. Healy

    
  • ·Prediction and prevention of suicide in mood disorders

    Page :45-45

    Z. Rihmer

    
  • ·Suicide prevention: Updated findings

    Page :45-46

    L. Tondo

    Résumé Résumé Plan Plan

• Symposium: Pharmacological prevention of suicide

  • ·Suicidal behaviour in the forthcoming classifications of mental disorders

    Page :46-46

    E. Vieta

    

• 8 April 2008 Core Symposium: Phenotype genotype endophenotype and the development in eating disorders

  • ·Gene-environment interaction in anorexia nervosa

    Page :46-46

    A.F.K. Karwautz, G. Wagner, K. Waldherr, F. Fernandez-Aranda, I. Krug, M. Ribases, J. Holliday, D.A. Collier, J.L. Treasure

    
  • ·Developmental continuities in eating and nutrition

    Page :46-46

    F. Fernandez-Aranda, I. Krug, D. Collier, A. Karwautz, J. Treasure

    
  • ·Cognitive inflexibility in anorexia nervosa - An FMRI perspective

    Page :46-47

    H.C. Friederich, A. Zastrow, S. Kaiser, C. Stippich, K. Tchanturia, W. Herzog

    Résumé Résumé Plan Plan

• 8 April 2008 Core Symposium: Phenotype genotype endophenotype and the development in eating disorders

  • ·The cycle of risk. The factors involved in the transmission of eating disorders between mothers and children

    Page :47-47

    F. Monneyron, N. Micali

    

• Presidential Symposium: Forensic psychiatry issues in Europe

  • ·The role of forensic psychiatry in mental health systems in Europe

    Page :47-47

    N. Nedopil

    
  • ·The interface between general and forensic psychiatry

    Page :47-48

    H. Gordon

    Résumé Résumé Plan Plan

• Presidential Symposium: Forensic psychiatry issues in europe

  • ·Quality assurance in forensic psychiatry

    Page :48-48

    H. Sass

    

• Workshop: Scientific reading and writing in psychiatry

  • ·Publication trends in high impact factor journals 1994-2004

    Page :48-48

    B. Schrank, M. Amering

    
  • ·Qualitative research methods in psychiatric science

    Page :48-48

    B. Schulze

    
  • ·Current developments and challenges for publishing houses

    Page :48-48

    J. Marsh

    
  • ·Why books?

    Page :48-49

    G. Stanghellini

    Résumé Résumé Plan Plan

• Workshop: Danish national schizophrenia project, 5 years follow up

  • ·The Danish national schizophrenia project – two- and five-year follow-up

    Page :49-49

    B. Rosenbaum, S. Harder, A. Køster, P. Knudsen, M. Lajer, A. Lindhardt, K. Valbak, G. Winther

    
  • ·Mental health services in Denmark. Where are people with schizoprenia treated in the danish national schizophrenia project?

    Page :49-49

    A. Koster

    
  • ·The Danish national schizophrenia project. Premorbid functioning and early course in first episode psychosis

    Page :49-49

    S. Harder, B. Rosenbaum

    
  • ·Danish national schizophrenia project. Psychiatric service development in Denmark during the course of DNS

    Page :49-50

    A. Lindhardt, A. Køster, M. Lajer, B. Rosenbaum

    Résumé Résumé Plan Plan

• Workshop: Danish national schizophrenia project, 5 years follow up

  • ·Treatment as usual (tau) in the first episode psychosis (fep) with focus on continuity and compliance. The danish national schizophreniaproject

    Page :50-50

    M. Lajer, A. Køster, A. Lindhardt, B. Rosenbaum

    

• Symposium: Are there schizophrenia subtypes?

  • ·What psychopathology tells us about the nature of schizophrenia?

    Page :50-50

    M.J. Cuesta, V. Peralta

    
  • ·Deteriorating/no deteriorating cognitive subtypes within schizophrenia

    Page :50-50

    M. Davidson

    
  • ·Longitudinal stability and long-term outcome of schizophrenia deficit and nondeficit subtypes

    Page :50-51

    S. Galderisi, G.B. Cassano, A. Rossi, A. Vita, L. De Peri, A. Mucci, S. Pini, P. Stratta, M. Maj

    Résumé Résumé Plan Plan

• Symposium: Are there schizophrenia subtypes?

  • ·Episodic memory in subtypes of schizophrenia

    Page :51-51

    P. Brazo, M. Ilongo-Lietout, S. Dollfus

    

• Symposium: How to organize integrated care in Europe?

  • ·Integrated care in Europe - The Dutch model

    Page :51-51

    D. Wiersma

    

• Symposium: How to organize integrated care in europe?

  • ·Integrated care in Europe - The case of Switzerland

    Page :51-51

    W. Rössler

    
  • ·Integrated primary care mental health services in England - Issues in the care of patients with long term mental health conditions

    Page :51-52

    E.J. England

    Résumé Résumé Plan Plan

• Symposium: How to organize integrated care in europe?

  • ·First results of integrated care in Germany

    Page :52-52

    F. Schneider, T. Kircher, F. Bergmann

    

• Symposium: Common mental disorders in sub-Saharan Africa what lessons for the developed world?

  • ·What can we learn from the history of psychiatry in Africa?

    Page :52-52

    O. Gureje

    
  • ·Common mental disorders in sub-Saharan Africa - What lessons for the developed world

    Page :52-52

    F.G. Njenga

    
  • ·Psychosocial responses to HIV/AIDS pandemic in sub-Saharan Africa

    Page :52-53

    F. Kigozi

    Résumé Résumé Plan Plan

• Symposium: Common mental disorders in sub-Saharan Africa what lessons for the developed world?

  • ·Mental health programmes in Africa: Challenges and opportunities

    Page :53-53

    N. Sartorius

    

• YP Workshop: How to build a national trainee association

  • ·The collegiate's trainees' committee as gold standard for a young psychiatrists and trainees association

    Page :53-53

    J.N. Beezhold

    
  • ·Setting up a young psychiatrists and trainee organization while facing new challenges in a changing political context

    Page :53-53

    S.I. Gerber, I.T. Calliess

    
  • ·Poland in European union - New reality and new possibility

    Page :53-54

    E. Trypka

    Résumé Résumé Plan Plan

• Free Communications

  • ·Impact of audit and feedback on antipsychotic prescribing in schizophrenia

    Page :54-54

    A.J. Wheeler, V. Humberstone, E. Robinson, J. Sheridan, P. Joyce

    
  • ·Exploring the neural substrate of the vulnerability to first episode psychosis using FMRI

    Page :54-54

    M.M. Picchioni, P. Matthiasson, M. Broome, S. Weinstein, V. Giampietro, M. Brammer, S. Williams, P. McGuire

    
  • ·Improving quality of life for persons with schizophrenia: A multidisciplinary approach

    Page :54-54

    D.J. Corring

    
  • ·Psychiatrists’ attitudes to antipsychotic depot injections (II): Changes over 5 years

    Page :54-55

    M.X. Patel, I.B. Chaudhry, N. Husain, S. McLaughlin, P. Cunningham, A.S. David, P.M. Haddad

    Résumé Résumé Plan Plan

• Free Communications

  • ·Schizophrenia: What do we know from functional magnetic resonance imaging?

    Page :55-55

    M. Van den Noort, P. Bosch

    

• Symposium: Network research in schizophrenia - A perspective for future research?

  • ·How to run network research: Experiences from the German Research Network on Schizophrenia (GRNS)

    Page :55-55

    W. Woelwer, W. Gaebel

    
  • ·Experiences from Danish network projects

    Page :55-56

    M. Nordentoft

    Résumé Résumé Plan Plan

• Symposium: New developments in consultation-liaison psychiatry

  • ·Developing treatments for somatisation - The model from irritable bowel syndrome

    Page :56-56

    F. Creed

    
  • ·Psychodermatology - yesterday, today, and tomorrow

    Page :56-56

    M. Musalek

    
  • ·Cl service in modena: The Italian experience

    Page :56-56

    M. Rigatelli, S. Ferrari, L. Pingani

    
  • ·Training issues in C-L psychiatry and psychosomatics – An international perspective

    Page :56-57

    D. Georgescu, A. Diefenbacher

    Résumé Résumé Plan Plan

• CME Course: The management of substance misuse in pregnancy

  • ·The epidemiology of substance misuse in pregnancy including physical and psychiatric comorbidity

    Page :57-57

    M. Kumar

    
  • ·Treatment of alcohol problems in pregnancy and prevention of fetal alcohol syndrome

    Page :57-57

    I.B. Crome

    
  • ·Management of illicit drug misuse and maternal and child outcomes

    Page :57-57

    U. Havemann-Reinecke

    
  • ·Macroscopic probes of brain dysmaturation in (developmental) pathopsychology

    Page :57-58

    J.L. Martinot, P. McGuire, S. Frangou, T. Kircher, M.L. Paillère-Martinot, A. Galinowski, R. De Beaurepaire, E. Artiges, F. Bellivier, E. Duchesnay, J. Pentillä, M. Plaze, J.F. Mangin, A. Cachia

    Résumé Résumé Plan Plan

• Symposium: Genomic imaging in schizophrenia

  • ·Imaging genetics in the Edinburgh high risk study

    Page :58-58

    S.M. Lawrie

    
  • ·Candidate genes and brain cortical morphology in schizophrenia

    Page :58-58

    I. Agartz, K. Varnäs, G. Lawyer, E.G. Jönsson, B. Kulle, R. Nesvåg, H. Hall, L. Terenius, P. Saetre

    
  • ·Interpersonal psychotherapy - New results in chronic depression

    Page :58-59

    E. Schramm

    Résumé Résumé Plan Plan

• Symposium: Psychotherapy of chronic depression – different approaches, equal efficacy?

  • ·Cognitive behavioral therapy of chronic depression

    Page :59-59

    M. Hautzinger

    
  • ·Cognitive Behavioral Analysis System of Psychotherapy (CBASP) - A new approach for chronic depression

    Page :59-59

    D.J.F. Van Schaik, P. Van Oppen, J. Wiersma, A.T.F. Beekman

    
  • ·Catie and StarD

    Page :59-60

    A. Joubert

    Résumé Résumé Plan Plan

• Symposium: Excessive gambling in a hedonistic society

  • ·Pathological, problem and at-risk gambling in German- and Italian-speaking Switzerland assessed with a DSM-IV-based instrument

    Page :60-60

    J. Brodbeck, H. Znoj

    
  • ·Prevalence of pathological gambling in Switzerland: A replication study

    Page :60-60

    C. Osiek

    
  • ·Prevention of gambling behavior in Switzerland

    Page :60-60

    M. Rihs-Middel

    
  • ·Neurophysiological and neuropsychiatric aspects of pathological gambling

    Page :60-60

    J. Grivel

    
  • ·Treatment-seeking gamblers and Parkinson's disease: Case reports

    Page :60-61

    O. Simon

    Résumé Résumé Plan Plan

• Symposium: The role of 5-HT1AR in pathophysiology and treatment of schizophrenia

  • ·The postsynaptic 5-HT1A-receptor and its role for cognitive functions in mice

    Page :61-61

    B. Bert, J. Rothe, H. Fink

    
  • ·Effect of Serotonin-1A receptor on behavioral changes in animal model of schizophrenia-like behavior

    Page :61-61

    V. Bubenikova-Valesova, M. Votava, T. Palenicek, J. Horacek, C. Hoschl

    
  • ·The influence of polymorphism for Serotonin 5HT-1A receptor on phenotypic variables in schizophrenia

    Page :61-62

    J. Horacek, F. Spaniel, M. Brunovsky, T. Novak, B. Tislerova, M. Kopecek, P. Mohr, C. Hoschl

    Résumé Résumé Plan Plan

• Symposium: The role of 5-HT1AR in pathophysiology and treatment of schizophrenia

  • ·Serotonin-1A agonists as a cognitive enhancer in schizophrenia: Clinical evidence

    Page :62-62

    T. Sumiyoshi, T. Uehara, T. Matsuoka, Y. Higuchi, T. Ito, H.Y. Meltzer

    

• Free Communications

  • ·New psychotherapeutic package for PTSD- patients without marked personality disorders

    Page :62-62

    I.D. Note, E.M. Grosse

    
  • ·PTSD Symptoms: Results of trauma or correlates of psychosocial characteristics?

    Page :62-63

    B.S. Rosenthal, W.C. Wilson

    Résumé Résumé Plan Plan

• Free Communications

  • ·Predictors of response to pharmacotherapy in mood and anxiety disorders: Commonalities, differences and indications

    Page :63-63

    A. Chiesa, R. Calati, A. Serretti

    
  • ·Depression and anxiety of CABG patients - long-term follow-up

    Page :63-63

    J. Rymaszewska, R. Wojtynska, P. Biecek, W. Kustrzycki, K. Dzielak

    
  • ·Observational studies in depression

    Page :63-64

    N. Dantchev

    Résumé Résumé Plan Plan

• Symposium: Longitudinal findings of a european study in depression (finder)

  • ·Health related quality of life outcomes in a depressed population 6 months after treatment initiation: Results from the FINDER study

    Page :64-64

    A.L. Montejo

    
  • ·Prevalence of pain in depression and health related quality of life outcomes: Results from FINDER

    Page :64-64

    L. Grassi

    
  • ·Six month outcomes for different baseline ‘caseness’ status: A closer look at depression, anxiety and comorbid depression and anxiety

    Page :64-64

    K. Demyttenaere

    
  • ·Patterns of antidepressant use in routine care of depressive outpatients in a 6-month European observational study: Results from finder

    Page :64-65

    M. Bauer

    Résumé Résumé Plan Plan

• Symposium: Effective treatment in borderline personality disorder – Approaches from general and disorder-specific psychotherapies

  • ·The currency makes all the difference! Why the therapeutic relationship should be tailored around the patients’ motives

    Page :65-65

    F. Caspar

    
  • ·Effectiveness of dialectical behavioral therapy for borderline personality disorder under inpatient conditions: A controlled trial and follow-up data

    Page :65-65

    M. Bohus

    
  • ·Schema-focused therapy for borderline personality disorder: Effectiveness and cost-effectiveness, evidence from a multicenter trial

    Page :65-66

    A. Arntz

    Résumé Résumé Plan Plan

• Symposium: Psychopathology: Phenomenology, nosology and cultural diversity

  • ·Western postmodern thinking and psychopathology: Dangers and chances

    Page :66-66

    M. Musalek

    
  • ·European and african psychopathology. What differences express the same subjectivity

    Page :66-66

    P. Varandas

    
  • ·When the healer is ill

    Page :66-66

    A.M. Ulman

    
  • ·Towards a cultural psychopathology

    Page :66-67

    A. D'angio'

    Résumé Résumé Plan Plan

• Symposium: Self-injurious behavior and suicidal behavior in adolescents

  • ·The neurobiology and genetics of suicidal behavior in adolescence

    Page :67-67

    G. Zalsman

    
  • ·Epidemiology and psychological correlates of deliberate self-harm in adolescents

    Page :67-67

    F. Resch, P. Parzer, J. Haffner, R. Steen, J. Roos, M. Klett, R. Brunner

    
  • ·Emotion regulation; Temperament and self-injurious behaviour in female adolescent with borderline personality disorder

    Page :67-67

    R. Brunner, P. Parzer, I.A. von Ceumern, F. Resch

    
  • ·Course of psychopathology in putatively prodromal subjects in the EPOS study

    Page :67-68

    S. Ruhrmann, F. Schultze-Lutter, H. Graf von Reventlow, H. Picker, M. Neumann, R.K.R. Salokangas, M. Heinima, D. Linszen, P. Dingemans, M. Birchwood, P. Patterson, G. Juckel, A. Morrison, J. Klosterkoetter

    Résumé Résumé Plan Plan

• 9 April 2008 Symposium: EPOS - further results of the completed study

  • ·Subjective quality of life and its changes in patients at risk of psychosis

    Page :68-68

    R.K. Salokangas, M. Heinimaa, T. Svirskis, J. Klosterkoetter, S. Ruhrmann, H. Graf von Reventlow, D.H. Linszen, P.M. Dingemans, M. Birchwood, P. Patterson, G. Juckel, A. Morrison

    
  • ·Transition to psychosis: Neuropsychological test results of the epos study

    Page :68-69

    D.H. Linszen, D.H. Nieman, H.E. Becker, P.M. Dingemans, J. Klosterkoetter, M. Birchwood, R.K. Salokangas, S. Ruhrmann, G. Juckel, A. Morrison, P. Patterson, M. Heinimaa, H. Graf von Reventlow

    Résumé Résumé Plan Plan

• 9 April 2008 Symposium: EPOS - further results of the completed study

  • ·The perception of expressed emotion in young people at high-risk of psychosis

    Page :69-69

    P. Patterson, M. Birchwood, A. Skeate, J. Klosterkoetter, S. Ruhrmann, H. Graf von Reventlow, R.K. Salokangas, M. Heinimaa, D.H. Linszen, P.M. Dingemans, G. Juckel, A. Morrison

    

• Symposium: Neuropsychobiology of inhibitory deficits in schizophrenia: An update

  • ·Antisaccade deficits in subjects either genetically or clinically at risk for schizophrenia

    Page :69-69

    M. Wagner, N. Petrovsky, J. Brinkmeyer, W. Woelwer, A. Bechdolf, S. Ruhrmann, J. Klosterkoetter, W. Maier, I. Frommann

    
  • ·Imaging and pharmacological studies of oculomotor inhibition

    Page :69-69

    U. Ettinger

    
  • ·Prepulse inhibition as a marker of prefrontal function: Studies in healthy individuals

    Page :69-70

    P. Bitsios

    Résumé Résumé Plan Plan

• Symposium: Neuropsychobiology of inhibitory deficits in schizophrenia: An update

  • ·Impaired sensorimotor gating of the acoustic startle response in the prodrome of schizophrenia

    Page :70-70

    B.B. Quednow, I. Frommann, J. Berning, K.U. Kühn, W. Maier, M. Wagner

    
  • ·Imaging and pharmacological studies of prepulse inhibition in schizophrenia

    Page :70-70

    V. Kumari

    
  • ·Cognitive assessment using cog-test battery of abnormal brain activation

    Page :70-71

    S. De Santi

    Résumé Résumé Plan Plan

• Symposium: The cognitive abnormalities as markers of abnormal brain activation

  • ·Neuromaging of cognitive impairment in schizophrenia and neurodegenerative disorders

    Page :71-71

    T. Sharma

    
  • ·Glutamatergic and dopaminergic system genes polymorphism in prefrontal tests performance in schizophrenia, bipolar disorders and in healthy subjects

    Page :71-71

    A. Borkowska

    
  • ·Neuropsychological prefrontal dysfunction in pathological obesity in the molecular genetics context

    Page :71-71

    A. Tretyn

    
  • ·Caregiver burden during a 2-year follow-up period

    Page :71-72

    A.M. Moeller-Leimkuehler

    Résumé Résumé Plan Plan

• Symposium: Family burden: Dimensions, determinants and interventions

  • ·Determinants of the caregiving appraisal

    Page :72-72

    M. Östman

    
  • ·Psychoeducational family interventions for schizophrenia: From RCT to routine clinical settings

    Page :72-72

    L. Magliano, A. Fiorillo

    
  • ·Caregivers in the process of treatment management

    Page :72-73

    J. Bäuml, G. Pitschel-Walz

    Résumé Résumé Plan Plan

• Symposium: Postnatal depression and effects of depression on breast milk

  • ·Service establishment for early diagnosis and prompt treatment of women with postnatal depression in tertiary care facility of Rawalpindi, Pakistan

    Page :73-73

    F.A. Minhas, A.T. Nizami, F.A. Khan

    
  • ·Maternal depression and infant growth – A crucial link

    Page :73-73

    A. Rehman, Z. Iqbal, J. Bunn, H. Lovel, R. Harrington, F.A. Minhas

    
  • ·Effect of maternal depression on intake of breastmilk in infants

    Page :73-73

    F.A. Minhas, A. Hafeez, A. Rehman

    
  • ·Comparative study of effect of Lactogouges (Metclopromide) and counselling on breastmilk production in mothers

    Page :73-74

    F.A. Minhas, A. Rehman, A. Hafeez, R. Bilal

    Résumé Résumé Plan Plan

• Free Communications

  • ·The decrease of prefrontal theta QEEG cordance value predicts response to Venlafaxine treatment in patients with resistant depression

    Page :74-74

    M. Bares, M. Brunovsky, M. Kopecek, T. Novak, P. Stopkova, J. Kozeny, P. Sos, V. Krajca, C. Höschl

    
  • ·One-year course and predictors of outcome of adolescent depression

    Page :74-74

    M.J. Marttunen, L. Karlsson, O. Kiviruusu, J. Miettunen, H. Heila, M. Holi, T. Ruuttu, V. Tuisku, M. Pelkonen

    
  • ·Drug consumption, health service use and outcome in opiate addicts in Europe: An 18-month follow-up from athens to zurich

    Page :74-75

    V. Reissner, A. Kokkevi, L. DiFuria, F. Schiffano, R. Room, R. Stohler, N. Scherbaum

    Résumé Résumé Plan Plan

• Free Communications

  • ·The neural correlates of decision-making in bipolar disorder: An fMRI study

    Page :75-75

    F. Gollier-Briant, J. Jogia, M. Haldane, M.J. Kempton, T. Christodoulou, S. Frangou

    
  • ·Substance use disorders among eating disorders and impulse control disorders: Personality and clinical correlates

    Page :75-75

    E.M. Alvarez-Moya, S. Jimenez-Murcia, Z. Aguera, L. Forcano, C. Villarejo, C.M. Bulik, F. Fernandez-Aranda

    
  • ·Toward DSM v: Why the new acute mental patient deserves more study

    Page :75-76

    A.V. Andreoli

    Résumé Résumé Plan Plan

• Symposium: The new acute mental patient: Diagnostic constructs and treatment innovation in emergency psychiatry

  • ·Learning from the longitudinal course of concurrent traumatic life events, major depression and personality disorders

    Page :76-76

    Y. Burnand, G. Rubovszky, D.I. Maire

    
  • ·Integrating emergency care, crisis intervention and acute treatment at the general hospital: Efficiency and costs

    Page :76-76

    P. Ohlendorf, D.I. Maire, M.F. Cochennec

    

• Symposium: Impulsivity, compulsivity and addiction

  • ·The role of impulsivity in the pathogenesis and treatment of addiction

    Page :76-76

    W. Van Den Brink

    
  • ·Neurobiological correlates of impulsivity and addiction

    Page :76-77

    A. Heinz

    Résumé Résumé Plan Plan

• Symposium: Impulsivity, compulsivity and addiction

  • ·Uncovering decision making strategies in drug misusers

    Page :77-77

    C. Newman

    
  • ·Psychopathology of impulse control

    Page :77-77

    M. Musalek

    

• Symposium: Characterization of second generation antipsychotic drugs: The role of electrophysiology

  • ·EEG abnormalities under first and second generation antipsychotics

    Page :77-77

    O. Pogarell, S. Karch, G. Leicht, C. Mulert

    
  • ·Topographic and tomographic QEEG changes induced by antipsychotic drugs

    Page :77-78

    M. Brunovsky, B. Tislerova, P. Sos, J. Horacek, M. Klirova, T. Novak, C. Hoschl

    Résumé Résumé Plan Plan

• Symposium: Characterization of second generation antipsychotic drugs: The role of electrophysiology

  • ·ERP changes induced by antipsychotic drugs

    Page :78-78

    A. Mucci, S. Galderisi, M. Piccirillo, E. Merlotti, M. Maj

    
  • ·Sleep EEG changes induced by antipsychotics

    Page :78-78

    M.J. Barbanoj, S. Giménez, S. Clos, S. Romero, E. Grasa, J. Riba

    
  • ·Suicide prevention for the person” - A subjectivistic approach outgoing from an European perspective

    Page :78-79

    W. Rutz

    Résumé Résumé Plan Plan

• Symposium: Novel perspectives in prevention of suicidal behaviours

  • ·Detection, evaluation and support for suicidal crisis : A French teaching program for caregivers

    Page :79-79

    J.P. Kahn

    

• Symposium: Alcoholism and drug addiction: Young researchers symposium

  • ·Benzodiazepines vs Clomethiazol in alcohol withdrawal treatment

    Page :79-79

    W. De Millas

    
  • ·Decision making and addiction - can addicts learn to forgo immediate reward?

    Page :79-79

    C. Newman

    
  • ·Prevalence and assessment of substance misuse in pregnancy in a UK setting

    Page :79-80

    M. Kumar

    Résumé Résumé Plan Plan

• Symposium: Alcoholism and drug addiction: Young researchers symposium

  • ·The evaluation of analgesics use (and misuse) in patients with haemophilia

    Page :80-80

    B. Avgustin

    

• Poster Session I: Stress

  • ·Sexual Violence among women in Marrakech

    Page :81-81

    I. Adali, S. Boutabia, S. Bououda, R. Chagh, F. Asri, F. Manoudi, I. Tazi

    
  • ·The presence of childhood sexual abuse a risk for antithyroid antibodies posivity in the postpartum depression. A preliminary study

    Page :81-81

    A. Plaza, L.L. Garcia-Esteve, P. Navarro, C. Ascaso, M. Piñeiro, R. Martin-Santos, E. Gelabert

    
  • ·Comparison of serum level of Brain-Derived Neurotrophic factor and Hypothalamus-Pituitary-Adrenal axis functioning in clinical burnout with controls

    Page :81-82

    I.T. Binbay, O. Onen Sertoz, E. Koylu, A. Noyan, E. Yildirim, H. Elbi Mete

    Résumé Résumé Plan Plan

• Poster Session I: Stress

  • ·Sexual dysfunction in veterans with PTSD

    Page :82-82

    D. Britvic, V. Anticevic, V. Kekez

    
  • ·School maladjustment at initial pupils from victim families

    Page :82-82

    G.G. Butorin, N.E. Butorina, L.A. Benko

    
  • ·Impact of intensity of traumatic experience on level of percieved competency and Self-Esteem of survivors

    Page :82-83

    L. Cakovic

    Résumé Résumé Plan Plan

• Poster Session I: Stress

  • ·Genetic variation in stress response: The role of the arginine vasopressin 1b receptor and the glucocorticoid receptor genes

    Page :83-83

    D. van West, D. Deboutte, S. Claes

    
  • ·Promoting mental health - Evidence of the Salutogenic Framework for a positive health development

    Page :83-83

    M. Eriksson, B. Lindstrom

    
  • ·Prevalence of risk for mental disorders among paramedical students at the Fatemeh nursing college. Shiraz-Iran

    Page :83-83

    S. Gholamzadeh, N. Passyar, A. Haghshenas

    
  • ·Prevalence of risk for mental disorders among paramedical students at the fatemeh nursing and midwifery college.Shiraz-Iran

    Page :83-84

    S. Gholamzadeh, A. Haghshenas

    Résumé Résumé Plan Plan

• Poster Session I: Stress

  • ·The dynamics of stress and changes in the working conditions

    Page :84-84

    E.N. Gruber, M. Katić, M. Agius

    
  • ·Classical and alternative pathways complement activity in patients with Post-Traumatic stress disorder

    Page :84-84

    L.P. Hovhannisyan, G.M. Mkrtchyan, A.S. Boyajyan, S.H. Sukiasyan

    
  • ·Muslim Suicide -Kashmir experience

    Page :84-84

    A. Hussain

    
  • ·Tracking stress and personality changes daily via Internet

    Page :84-85

    Y. Ishizuka

    Résumé Résumé Plan Plan

• Poster Session I: Stress

  • ·Absconding by patients from psychiatric hospital

    Page :85-85

    R. Kigli, D. Amital, A. Barzilay, T. Katz, Z. Marzayev, M. Kotler

    
  • ·Adult life events increase the risk of Cardiovascular Disease and Depressiveness among those with childhood adversities

    Page :85-85

    K. Korkeila, J. Korkeila, J. Vahtera, L. Sillanmäki, M. Koskenvuo

    
  • ·Assessment of stress at work

    Page :85-86

    A.V. Mazgutov, A. Burtenshaw

    Résumé Résumé Plan Plan

• Poster Session I: Stress

  • ·A survey to assess burnout of physicians working in the belgian pharmaceutical industry

    Page :86-86

    P. Mesters, M. Czarka, N. Schepers, D. Renard

    
  • ·Sleep spindles in kindergarten children: Relation to sleep and Hypothalamic-Pituitary-Adrenocortical (Hpa) activity

    Page :86-86

    T. Mikoteit, S. Brand, J. Beck, E. Holsboer-Trachsler, M. Hatzinger

    
  • ·Clinical-Immunological criteria of prognosis of prolonged course of posttraumatic stress disorders

    Page :86-87

    V.B. Nikitina, T.P. Vetlugina, E.M. Epanchintseva

    Résumé Résumé Plan Plan

• Poster Session I: Stress

  • ·Is psychiatry such a stressful profession?

    Page :87-87

    B. Pejuskovic, D. Lecic Tosevski, O. Toskovic

    Plan Plan
  • ·Burnout among physicians

    Page :87-87

    N. Pranjic

    
  • ·Suicidal behavior and stress related disorders

    Page :87-87

    P. Pregelj, M. Tomori, J. Balazic, T. Zupanc

    
  • ·Psychosocial distress as a risk factor for diabetes mortality

    Page :87-88

    Y.E. Razvodovsky

    Résumé Résumé Plan Plan

• Poster Session I: Stress

  • ·Burnout, coping and job satisfaction in service staff treating opioid addicts – from Athens to Zurich

    Page :88-88

    V. Reissner, B. Baune, V. Votsidi, F. Schifano, R. Room, R. Stohler, C. Schwarzer, N. Scherbaum

    
  • ·Acculturative stress and psychopathology in an immigrant population in primary care

    Page :88-88

    H.W. Revollo, A. Qureshi, F. Collazos, M. Ramos, N. Sobradiel

    
  • ·Stress, mental health and satisfaction among women doctors in England

    Page :88-89

    U. Rout, R. Rout, J.K. Rout

    Résumé Résumé Plan Plan

• Poster Session I: Stress

  • ·Posttraumatic growth within war torture survivors in Bosnia and Herzegovina

    Page :89-89

    D. Salcic, A. Bravo Mehmedbasic, A. Kucukalic, S. Fadilpasic

    
  • ·Childhood Trauma, alterations of Hypothalamic-Pituitary-Adrenocorticol (HPA) Activity, and Psychopathology in patients with Alcohol Dependence

    Page :89-89

    I. Schafer, K. Homann, J. Schulze-Thusing, L. Teske, J. Hissbach, C. Haasen, K. Wiedemann

    
  • ·Affective model of stress related disorders: State-Trait approach

    Page :89-89

    O.F. Seravina, K.B. Kovalevskaya, D.Y. Veltishchev

    
  • ·Synergetics of syndrome of professional burnout in psychiatric community

    Page :89-90

    P.I. Sidorov

    Résumé Résumé Plan Plan

• Poster Session I: Stress

  • ·Influence of stressful life events frequency on multiple sclerosis disease activity

    Page :90-90

    C.I. Mitsonis, I.M. Zervas, N.P. Dimopoulos, V.V. Psara, G.P. Sotiropoulos, C.M. Potagas, C.A. Sfagos, G.N. Papadimitriou

    
  • ·Narrative Exposure Therapy compared to treatment as usual for refugees with PTSD - Preliminary results from a randomized controlled trial

    Page :90-90

    H. Stenmark, C. Catani, T. Elbert, K.G. Gøtestam

    
  • ·Social functioning and stress coping in schizophrenic patients

    Page :90-91

    M. Vrdoljak, S. Ivezić, M.K. Jukić

    Résumé Résumé Plan Plan

• Poster Session I: Stress

  • ·Role of psychogenic and stress factors in the formation of clinical forms of mental disorders

    Page :91-91

    B.D. Tsygankov, D.F. Khritinin, D.B. Tsygankov, Y.T. Janguildin, Y.A. Shchetinina

    

• Poster Session I: Personality Disorders

  • ·Relationship of substance use disorder to aggression in male subjects with antisocial personality disorder

    Page :91-91

    A. Algul, M.A. Ates, U.B. Semiz, C. Basoglu, S. Ebrinc, O. Gecici, S. Iyisoy, M. Cetin

    
  • ·Alexithymia and aggression in patients with antisocial personality disorder

    Page :91-91

    M.A. Ates, U.B. Semiz, A. Algul, S. Ebrinc, C. Basoglu, S. Iyisoy, O. Gecici, M. Cetin

    
  • ·Personality types of cluster B: Similiraties and dissimilarities in a tunisian psychiatric outpatient unit

    Page :91-92

    Y. El Kissi, M. Ayachi, S. Ben Nasr, A. Mansour, B. Ben Hadj Ali

    Résumé Résumé Plan Plan

• Poster Session I: Personality Disorders

  • ·Medico-Legal acts and epilepsy

    Page :92-92

    S. Boutabia, F. Manoudi, S. Bouaouda, I. Adali, R. Chagh, F. Asri, I. Tazi

    
  • ·Impaired making-decision and empathy disorder in psychopathy

    Page :92-92

    C. Boulanger, M. Habib, C. Lançon

    
  • ·Screening of personality disorders for gender among Spanish college students by personality diagnostic questionnaire-4+ (Pdq-4+)

    Page :92-93

    N. Calvo, O. Andion, M. Ferrer, X. Caseras, R. Torrubia

    Résumé Résumé Plan Plan

• Poster Session I: Personality Disorders

  • ·Open-label treatment with olanzapine in patients with borderline personality disorder

    Page :93-93

    M.C. Zanarini, S.C. Schulz, H.C. Detke, F. Zhao, D. Lin, W. Deberdt, S. Corya

    
  • ·Personality factors and profile in variants of irritable bowel syndrome

    Page :93-93

    A.R. Farnam, M.H. Somi, S. Farhang, F. Sarami

    
  • ·Influence of topiramate in risk behaviors reduction with borderline personality disorder patients treated by DBT

    Page :93-94

    M. Ferrer, O. Andion, N. Saez, C. Barral, L. Alvarez-Cienfuegos, N. Calvo, A. Salmaso, M. Casas

    Résumé Résumé Plan Plan

• Poster Session I: Personality Disorders

  • ·Disorganized attachment and genetics in the development of borderline personality disorder

    Page :94-94

    X. Fosse, J.L. Monestes, B. Bakhache

    
  • ·Conduct disorder in former USSR immigrant adolescents and the role of parenting style and ego identity

    Page :94-94

    P. Golubchik, R. Finzi-Dottan, R. Bilu

    
  • ·Alopecia areata in female patient suffering from borderline personality disorder (with co-occurring mood disorder, present episode depressive)

    Page :94-94

    E.N. Gruber, M. Bjedov

    
  • ·A new strategy for treatment of borderline personality disorder

    Page :94-95

    Y. Ishizuka

    Résumé Résumé Plan Plan

• Poster Session I: Personality Disorders

  • ·Is there any influence of personality disorder on the treatment of social phobia?

    Page :95-95

    J. Vyskocilova, J. Prasko, T. Novak, K. Adamcova, L. Pohlova

    
  • ·Augmentation of antidepressants with bright light therapy in patients with comorbid depression and borderline personality disorder

    Page :95-95

    J. Prasko, K. Adamcova, M. Brunovsky, R. Nechutna, J. Vyskocilova, L. Zavesicka

    
  • ·Borderline personality – bad behavior as illness

    Page :95-95

    J. Korkeila

    
  • ·Emotional information-processing in borderline personality disorder: An EEG-study

    Page :95-96

    M. Marissen, I. Franken

    Résumé Résumé Plan Plan

• Poster Session I: Personality Disorders

  • ·Self-inflicted injury and outcome of treatment with borderline personality disorder patients

    Page :96-96

    P. Papadopoulos, D. Malidelis, A. Drositi, E. Panagoulias

    
  • ·The effect of paramedical students attitude toward their jobs on their self-concept at the Fatemeh nursing and midwifery college. Shiraz-Iran

    Page :96-96

    N. Passyar

    
  • ·Collaborating for change: Decreasing BPD environmental stressors. Teaching families to be adjuncts to treatment by applying DBT and mentalizing techniques

    Page :96-97

    V. Porr

    Résumé Résumé Plan Plan

• Poster Session I: Personality Disorders

  • ·Sexual behavior and borderline personality disorders

    Page :97-97

    R. Sala Cassola

    
  • ·Facial emotional recognition in borderline personality disorder

    Page :97-97

    S. Subira Alvarez, M. Vallez, L. Ferraz, J.B. Navarro

    
  • ·Analogies between punishment and obsession-compulsion: Evidences of a social apprenticeship

    Page :97-97

    J.M. Vargas Ponciano

    Plan Plan
  • ·Negation to execute conditioned reflexes: Origin of the mental illness

    Page :98-98

    J.M. Vargas Ponciano

    Plan Plan
  • ·From personality disorders towards personality development disorders

    Page :98-98

    F. Versonnen, S. Tuinier

    

• Poster Session I: Schizophrenia and Psychosis

  • ·Survey of relation between positive and negative symptoms in schizophrenic patients with history and risk of suicidal attempt

    Page :98-98

    E. Abdollahian, M.S. Forghani, M. Modares Gharavi

    
  • ·Nursing demands of patients with schizophrenia after hospital treatment

    Page :98-99

    V. Adomaitiene, V. Taranda, Z. Tarandiene, K. Dambrauskiene, G. Jonusiene, A. Kunigeliene, D. Puteliene

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Four year follow up of patients discharged from early intervention for psychosis service to a community mental health team

    Page :99-99

    M. Agius, S. Shah, R. Ramkisson, R. Zaman

    
  • ·Issues regarding the delivery of early intervention for psychosis services to the South Asian population in England

    Page :99-99

    A. Talwar, M. Agius, R. Zaman

    
  • ·The pattern of development of psychotic symptoms after trauma

    Page :99-100

    M. Agius, H. Pepper, M. Sah, S. Jayalath, R. Pinto, R. Zaman

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Different pathways leading to suicide in schizophrenia

    Page :100-100

    A. Alaraisanen, J. Heikkinen, Z. Kianickova, J. Miettunen, P. Rasanen, M.K. Isohanni

    
  • ·Social phobic symptoms associated with atypical” antipsychotic treatment: A case report

    Page :100-100

    S. Antonatos

    
  • ·Catatonic schizophrenia at age 16: When neurology gives up!

    Page :100-100

    D.A. Barrocas, M.M. Abreu, R. Coentre, P.M. Levy

    
  • ·The effectiveness of a long term group therapy for patients with psychosis for diminishing the negative symptoms of psychosis

    Page :100-101

    B. Avgustin, M. Blinc Pesek, N. Perovsek Solinc

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·The importance of long term group therapy for diminishing the stigma of patients with psychosis

    Page :101-101

    B. Avgustin, M. Blinc Pesek, N. Perovsek Solinc

    
  • ·Suicide attempts of schizophrenia patients: A case-controlled study in tertiary care

    Page :101-101

    A. Aviv, Y. Barak, Y. Baruch, A. Achiron, D. Aizenberg

    
  • ·SMS in the outpatient treatment of schizophrenia: Feasibility and acceptance

    Page :101-102

    S. Bachmann, C. Ruddies, H. Kordy, S. Bauer

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Psychoeducation and knowledge gain in patients with schizophrenia under mono- and combined antipsychotic therapy: Comparison of amisulpride vs. other atypicals

    Page :102-102

    J. Baeuml, T. Froboese, A. Gsottschneider, S. Mueller, C. Pohl, C. Rummel-Kluge, G. Pitschel-Walz, F.X. Eich, T.H. Jahn

    
  • ·Caregivers in the treatment of management

    Page :102-102

    J. Baeuml, G. Pitschel-Walz

    
  • ·Delay of left hemisphere in processing information in schizophrenia?

    Page :102-103

    M. Baiano, S. Savazzi, S. Sponda, C. Perlini, G. Rambaldelli, M. Bellani, M. Tansella, C.A. Marzi, P. Brambilla

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·A study of relationship between psychopathology, insight and compliance in schizophrenia

    Page :103-103

    V. Bajaj, S.N. Sengupta, D.K. Gupta

    
  • ·The expression of positive and negative schizotypy in daily life: An experience sampling study

    Page :103-103

    T.R. Kwapil, N. Barrantes-Vidal, L.H. Brown, P.J. Silvia, I. Myin-Germeys

    
  • ·Psychopathology, social adjustment, and personality correlates of schizotypy clusters in a large non-clinical sample

    Page :103-103

    N. Barrantes-Vidal, K.E. Lewandowski, T.R. Kwapil

    
  • ·The dimensional structure of the Wisconsin schizotypy scales: Factor identification and construct validity

    Page :103-104

    T.R. Kwapil, P.J. Silvia, N. Barrantes-Vidal

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·The MAO-A VNTR polymorphism is an important determinant of working memory and sensorimotor gating

    Page :104-104

    P. Roussos, S.G. Giakoumaki, P. Bitsios

    
  • ·Influence of patients premorbid peculiarity, who in the first time ached schizophrenia in old age, on negative disorders

    Page :104-104

    P.O. Bomov, V.G. Budza, I.V. Gorodoshnikova

    
  • ·Schizophrenia: is therapy involving early warning symptoms and antipsychotics successful?

    Page :104-104

    M.P. Bosch

    
  • ·Schizophrenia and sleep disorders, their relation and treatment with acupuncture

    Page :104-105

    M.P.C. Bosch, M.W.M.L. Van den Noort

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Late factors of schizophrenia diagnosis

    Page :105-105

    S. Bouaouda, S. Boutabia, R. Chagh, I. Adali, F. Manoudi, F. Asri, I. Tazi

    
  • ·Cognitive and social rehabilitation in schizophrenia: The SAARP module

    Page :105-105

    C. Boulanger, C. Hervieux, C. Lancon

    
  • ·Delirious profile of Morrocan schizophrenics

    Page :105-105

    S. Boutabia, S. Bouaouda, F. Manoudi, F. Asri, I. Tazi

    
  • ·Left temporal hypoperfusion with impaired lexical access in schizophrenia: A case report

    Page :105-106

    F. Bretel, O. Guillin, G. Opolczynski, M. Petit, S. Haouzir

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Weight management by modular group interventions. Outcome at 24 months in an Irish cohort with severe mental illness (SMI)

    Page :106-106

    C.J. Bushe, C. Haley, D. McNamara, M. Fleming MCrossan, P. Devitt

    
  • ·Effectiveness and patterns of switching to aripiprazole in schizophrenic patients. Rea I and rea II studies

    Page :106-106

    F. Canas, M. Camacho, S. Ros, M. Serrano, Y. Riesgo, J. Luque, P. Vieitez, I. Barber

    
  • ·Sex differences in prodrome of first psychosis episodes

    Page :106-107

    A. Catalan, R. Segarra, M. Prieto, I. Eguiluz, E. Bravo, S. Enjuto, M. Gutierrez

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Sex differences in the outcome of first episode psychosis

    Page :107-107

    A. Catalan, M. Sanchez, R. Segarra, M. Prieto, M. Gutierrez, I. Eguiluz, C. Fernandez

    
  • ·Does contextual information cue comprehension of speaker intent in schizophrenia?

    Page :107-107

    M. Champagne-Lavau, E. Stip, G. Blouin, J.P. Rodriguez

    
  • ·A double-blind randomized placebo-controlled relapse prevention study in remitted first-episode psychosis patients following one year of maintanence therapy

    Page :107-108

    Y.H. Chen, L.M. Hui, M. Lam, C.W. Law, P.Y. Chiu, W.S. Chung, S. Tso, P.F. Pang, K.T. Chan, Y.C. Wong, F. Mo, P.M. Chan, S.F. Hung, W.G. Honer

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Weight gain as a marker of evolution to patients with multiple episodes schizophrenia and atypical antipsychotic treatment

    Page :108-108

    A. Chimorgiachis, D. Marinescu, M. Pirlog

    
  • ·Distinctive features of post-schizophrenic depression

    Page :108-108

    V. Kenchadze, E. Chkonia

    
  • ·Verbal memory characteristic of patient with paranoid schizophrenia and their first degree relatives

    Page :108-108

    E. Chkonia, A. Kezeli, L. Tsverava

    
  • ·Memory measures in healthy relatives of bipolar and schizophrenic probands

    Page :108-109

    T. Christodoulou, M. Hadjulis, S. Frangou, P.W. Burgess

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Executive function measures in healthy relatives of bipolar and schizophrenia probands

    Page :109-109

    T. Christodoulou, M. Hadjulis, S.J. Gilbert, S. Frangou, P.W. Burgess

    
  • ·Treatment of post-psychotic depression (PPD) in schizophrenia

    Page :109-109

    A.M. Ciobanu, A. Dragan, A. Beldie, E. Calinescu

    
  • ·The role of neuropsychological assessment in the comprehensive diagnosis of schizophrenia

    Page :109-110

    D.C. Cozman, S. Nica, B. Nemes, M.M. Manea, H.G. Coman

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Opioid withdrawal symptoms: Low efficacy of non-opioid drugs

    Page :110-110

    B. Croissant, D. Hermann, K. Mann

    
  • ·Amisulpride in combination: Saving potential in clozapine dosage; A case report

    Page :110-110

    B. Croissant, D. Hermann, R. Olbrich

    
  • ·Evaluation of selection cognitive functions in patients with schizophrenia

    Page :110-110

    M.M. Dabkowska, A. Araszkiewicz

    
  • ·The role played by sleep disturbances in the etiopathogeny of psychotic symptoms

    Page :110-111

    L. Dehelean

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Assertive community Treatment vs. Standard treatment: Hospitalisation frequency and duration, quality of life and functioning outcome

    Page :111-111

    I. Bulic Vidnjevic, A. Pirtovsek Savs, A. Winkler, M. Derganc, V. Svab

    
  • ·A comparision of switching strategies from risperidone to aripiprazole in patients with schizophrenia with insufficient efficacy/tolerability on risperidone (cn138-169)

    Page :111-111

    V. Rykmans, J.P. Kahn, A. Dillenschneider, L. Hanssens, S. Model, W. Kerselaers, J.Y. Loze, R. Sanchez

     
  • ·Erectile dysfunction and the role of phosphodiesterase-5 (PDE-5) inhibitors in schizophrenia. A brief review

    Page :111-112

    N.P. Dimopoulos, C.I. Mitsonis

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Frequency of rehospitalisation of schizophrenia patients

    Page :112-112

    N.S. Djokic, A.M. Petrovic, D.V. Vukic

    
  • ·Cardiovascular risk factors in a population of 25 Portuguese patients with schizophrenia

    Page :112-112

    I. Domingues, S. Timóteo, A. Norton, R. Correia, R. Malta, A. Martins, C. Silveira, R. Curral, J. Marques-Teixeira, A. Palha

    
  • ·Early detection of cardiovascular risk factors in schizophrenia

    Page :112-112

    I. Domingues, C. Silveira, R. Curral, J. Marques-Teixeira, A. Palha

    
  • ·Family history and its influence in the beginning and progress of mental disease

    Page :112-113

    G. Doulgeraki, A. Graikiotis, K. Theodosi, D. Kosma, N. Kavvadias, V. Aggeli, A. Pittara, M. Malatra

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Fighting stigma in schools: Pre, Post, and Follow-up results of an educational intervention

    Page :113-113

    M. Economou, H. Louki, M. Charitsi, A. Vernicos, E. Tsaliagou, D. Kolostoumpis, C.N. Stefanis

    
  • ·Duloxetine for major depressive episodes in the course of psychotic disorders: A prospective clinical trial

    Page :113-113

    S. Englisch, U. Knopf, B. Scharnholz, A. Kuwilsky, M. Deuschle, M. Zink

    
  • ·Efficiency of psychoeducational programs in schizophrenia patients

    Page :113-114

    A.N. Erichev

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Olfactory identification ability in schizophrenia spectrum disorders

    Page :114-114

    A. Farhoudian, S.V. Shariat, M. Taj, E. Shahsavand

    
  • ·Effects of selegiline on negative symptoms in schizophrenia

    Page :114-114

    M.R. Fayyazi Bordbar, E. Abdolahian, K. Hojjat

    
  • ·Weight change on aripiprazole-clozapine combination in schizophrenic patients with weight gain and suboptimal response on clozapine: 16-week double-blind study

    Page :114-115

    W.W. Fleischhacker, M.E. Heikkinen, J.P. Olié, W. Landsberg, P. Dewaele, R. McQuade, D. Hennicken

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Predicting 5-year outcome in first episode psychosis-construction of a prognostic rating scale

    Page :115-115

    L. Flyckt, M. Mattsson, G. Edman, R. Carlsson, J. Cullberg

    
  • ·Efficacy and tolerability of aripiprazole in adolescents with schizophrenia

    Page :115-115

    A. Forbes, M. Nyilas, J. Loze, C. Werner, B. Johnson, R. Owen, S. Todorov, W.H. Carson

    
  • ·Oxidative cell damage is related to the enlargement of the lateral ventricles in children and adolescents with first episode schizophrenia

    Page :115-116

    D. Fraguas, S. Reig, M. Desco, O. Rojas-Corrales, J. Gibert-Rahola, M. Parellada, D. Moreno, J. Castro-Fornieles, M. Graell, I. Baeza, A. Gonzalez-Pinto, S. Otero, C. Arango

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·The correlation between social interaction and intelect (iq) in schizophrenic patients

    Page :116-116

    I. Gabos Grecu, M. Gabos Grecu, C. Gabos Grecu, T. Moica

    
  • ·Validation of a scale measuring patient satisfaction with psychotropic treatment (pasap) on a sample of schizophrenic patients - espass study

    Page :116-116

    I. Gasquet, D. Legay, J.M. Azorin, J.Y. Loze, L. Depret-Bixio, R. Arnaud, F. Rouillion

    
  • ·Incomplete capgras syndrome as a rare varient of this syndrome

    Page :116-116

    A.G. Nejad

    
  • ·The VADO approach in psychiatric rehabilitation: A randomized controlled trial

    Page :116-117

    A. Gigantesco, P. Morosini, M. Vittorielli, R. Pioli

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·First health and nutritional survey of israeli schizophrenic patients - 2006

    Page :117-117

    F. Tsodikov, R. Chernyak, Y. Gimelfarb, Z. Natan

    
  • ·Quality of life in schizophrenia: Association with global functioning, symptomatology and neurocognition

    Page :117-117

    M. Giugiario, C. Montemagni, B. Crivelli, P. Rocca

    
  • ·Psychiatric manifestations during the course of late (tertiary) syphilis: Diagnostic dilemmas and therapeutic considerations a propos of a case report

    Page :117-118

    P. Goulia, I. Bassukas, C. Mantas, G. Giannakakis, V. Mavreas, T. Hyphantis

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·A study of comparison of components of insight in patients with schizophrenia and bipolar affective disorder in remission phase

    Page :118-118

    S. Govil, S.N. Sengupta, P. Sharma, D. Kumar

    
  • ·Working memory dysfunction as phenotypic marker of schizophrenic and bipolar affective psychoses: Common and differential abnormalities in brain activation

    Page :118-118

    O. Gruber, I. Henseler, H. Scherk, T. Wobrock, P. Falkai

    
  • ·Grey matter correlates of skin conductance levels in patients with schizophrenia and healthy volunteers: A voxel-based morphometry (vbm) study

    Page :118-118

    J.E. Hallak, T.B. Ferrari, J.A. Crippa, D. Araujo, A.C. Santos, A.W. Zuardi

    
  • ·Plasma concentrations of aminoacids in chronic non-refractory schizophrenia and their first-degree relatives compared to refractory schizophrenia and their first degree-relatives

    Page :118-119

    J.E. Hallak, M.T. Cunha, R.A. Gomes, A.W. Zuardi, S.M. Dursun

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Childhood subclinical characteristics in schizophrenia - a questionnaire-based retrospective study

    Page :119-119

    Y. Hamasaki, T. Murai

    
  • ·Anomalies of subjective experiences as basic phenotypes of schizophrenia spectrum disorders: A review of three emperical studies

    Page :119-119

    P. Handest, J. Parnas

    
  • ·Structural brain abnormalities in the early phase of schizophrenia

    Page :119-120

    R. Herold, A. Feldmann, T. Tenyi, F. Kover, S. Fekete

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·D-serine serum level - a marker of glutamatergic dysfunction in schizophrenia

    Page :120-120

    J. Hons, R. Zirko, J. Bazant, J. Libiger, M. Ulrychova, J. Vavrova, E. Cermakova

    
  • ·Psychose puerperale : Nouveaux concepts, nouvelles evolutions

    Page :120-120

    H.I. Penka

    
  • ·A double-blind randomized placebo-controlled study of relapse predictors in remitted first-episode psychosis patients

    Page :120-121

    L.M. Hui, Y.H. Chen, M. Lam, C.W. Law, P.Y. Chiu, W.S. Chung, S. Tso, P.F. Pang, K.T. Chan, F. Mo, P.M. Chan, S.F. Hung, W.G. Honer

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Evaluating decision criteria for the choice of pharmacological long-term therapy in risperidone treated patients with schizophrenia

    Page :121-121

    B. Ibach, M. Gerwe, L. Hargarter

    
  • ·Modalities of violence in schizophrenia

    Page :121-121

    P. Ittah, R. Gaillard, R. Gourevitch, F.J. Bayle

    
  • ·Cognitive improvement in schizophrenia after 6-month treatment with olanzapine

    Page :121-121

    K. Krysta, A. Klasik, I. Krupka-Matuszczyk, J. Przybylo, M. Janas-Kozik, M. Sygut

    
  • ·Cognitive functions in patients with schizophrenia and their correlation with anxiety

    Page :121-122

    K. Jeczminska, A. Kozmin, A. Krawiec, J. Jarnot, J. Dusik, A. Piwowarczyk, K. Krysta, M. Janas-Kozik, I. Krupka-Matuszczyk

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Efficacy of once-daily extended release quetiapine fumarate across symptom domains in schizophrenia

    Page :122-122

    R. Kahn, C. Schulz, V. Palazov, E. Reyes, D. Meulien, M. Brecher, O. Svensson, H.M. Andersson

    
  • ·Symptom profiles of obsessive compulsive disorder with comorbid schizophrenia and pure obsessive compusive disorder

    Page :122-122

    K.O. Karamustafalioglu, R. Demirer, N. Karamustafalioglu, S. Citak

    
  • ·Efficacy and tolerability of switching from olanzapine, risperidone and haloperidol to ziprasidone in patients with schizophrenia: An international multi-center study

    Page :122-123

    K. Alptekin, O.N. Karayal, S. Brook, C. Akkaya, E. Tzebelikos

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Unitary psychosis an evidence from early psychosis

    Page :123-123

    M.H. Khan, H.R. Chaudhry, M.G. Butt, Z. Mukhtar, M. Haq, A. Bakar

    
  • ·Phenomenon of loneliness in structure of apathy abulia syndrome

    Page :123-123

    A.S. Kim, S.M. Karypbaeva

    
  • ·Evidence for a normally functioning mirror system in schizophrenia

    Page :123-124

    J. Kinross, V. Kumari, S. Frangou

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Refusal to eat, as a symptom of schizophrenia, can result in cachexia, phenomenologically resembling comorbid anorexia nervosa

    Page :124-124

    E. Ozan, E. Yazici, E. Deveci, S. Algul, I. Kirpinar

    
  • ·Place and clinical features of schizotypal personality disorders in schizophrenic spectrum

    Page :124-124

    E.V. Klembovskaya

    
  • ·The Danish national schizophrenia project: Response to clinical treatment according to gender in first episode psychosis

    Page :124-125

    A. Koester, M. Lajer, A. Lindhardt, B. Rosenbaum

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Effect of schizotypy on hemispheric differences in language comprehension

    Page :125-125

    C. de Loye, M. Kostova

    
  • ·"Breakwater"- The preventive and therapeutic programme for the first degree relatives of schizophrenic patients

    Page :125-125

    M. Kotlicka-Antczak, J. Rabe-Jablonska

    
  • ·Correlation of functioning and self feeling in schizophrenia

    Page :125-125

    J. Kafel, M. Derejczyk, L. Cichon, A. Arczynska, K. Krysta, I. Krupka-Matuszczyk

    
  • ·Shizophrenia-spectrum disorders with syndrome of sexual dysphoria

    Page :125-126

    S.B. Kulish, S.N. Matevossian

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Subjective improvement and symptom change in psychosis

    Page :126-126

    Z. Kupper, W. Tschacher

    
  • ·Impact of risperidone long-acting injection verus oral antipsychotic treatments on hospitalization in schizophrenia

    Page :126-126

    J.M. Olivares, A. Morales Rodriguez, J. Diels, M. Povey, A. Lam, Z. Zhao

    
  • ·Clinical and functional outcomes of patients with schizophrenia treated with risperidone long-acting injection versus oral antipsychotics

    Page :126-127

    J.M. Olivares, A. Rodriguez Morales, J. Diels, M. Povey, A. Lam, Z. Zhao

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Clinical and functional improvements with risperidone long-acting injection treatment: 6-month results from the electronic schizophrenia treatment adherence registry in Sweden

    Page :127-127

    L. Eriksson, M. Povey, B. Eriksson, A. Lam, Z. Zhongyun

    
  • ·Reduction in suicidal ideation and violent behavior after treatment with risperidone long-acting injection from the e-star project in The Netherlands

    Page :127-127

    M. van Kooten, E. de Groot-Stam, C.L. Mulder, M. Povey, M. Manders, A. Lam, Z. Zhao

    
  • ·Does computerized cognitive remediation change brain activation patterns in schizophrenia: fMRI pilot data

    Page :127-128

    J. Lindenmayer, S. Kaushik, C. Branch, S. McGurk, A. Khan, H. Li, L. Hoffman

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Assessment of body fat % in patients treated with sertindole or olanzapine

    Page :128-128

    Y. Linne von Hausswolff-Juhlin, S. Rossner, M. Neovius

    
  • ·Immune parameters and aminotransferase blood serum level in dynamics of atypical neuroleptics treatment of schizophrenic patients

    Page :128-128

    O.A. Lobacheva, T.P. Vetlugina, A.V. Semke, T.A. Popova

    
  • ·Genious study: The use of ziprasidone for the treatment of patients with schizophrenia

    Page :128-129

    L. Lyras, N. Tzavaras, G. Kaprinis, A. Karavatos, I. Mantonakis, E. Tzebelikos

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Negative symptoms precede the onset of first episode psychosis in a prospective general population sample of adolescents

    Page :129-129

    P.H. Maki, J. Miettunen, M. Kaakinen, I. Moilanen, A. Taanila, P.B. Jones, G. Murray, M. Joukamaa, M. Heinimaa, J.M. Veijola

    
  • ·EEG abnormalities and three year outcome in first episode psychosis

    Page :129-129

    R. Manchanda, R. Norman, A. Malla, R. Harricharan, S. Northcott

    
  • ·Psychotic disorder in a 60-year-old woman diagnosed with uterine cervical cancer: A case report

    Page :129-130

    M. Manea, B.E. Patrichi, V. Rusanu, M.G. Puiu, M.R. Stoean

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·The hypofrontality and working memory

    Page :130-130

    V. Mangubi

    
  • ·Self mutilation (five cases reports)

    Page :130-130

    F. Manoudi, S. Bouaouda, S. Boutabia, A. Adali, R. Chagh, F. Asri, I. Tazi

    
  • ·Axis I anxiety disorders comorbidity in psychotic patients

    Page :130-131

    A. Ciapparelli, R. Paggini, D. Marazziti, C. Carmassi, M. Bianchi, C. Taponecco, G. Consoli, V. Lombardi, L. Dell'Osso

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Platelet serotonin and serum cholesterol concentrations in suicidal and non-suicidal male patients with first episode of psychosis

    Page :131-131

    D. Marcinko, M. Jakovljevic, N. Pivac, D. Muck-Seler

    
  • ·Diagnostic and therapeutical approach in psychosis - pituitary adenoma comorbidity. Case report

    Page :131-131

    G. Marian, B.E. Ionescu, D. Ghinea, E.A. Nica

    
  • ·Blood glucose level in the patients with schizophrenia

    Page :131-131

    M. Maroufi, F. Kianvash

    
  • ·Sensitivity of comparisons of TTAD across antipsychotics to patient selection criteria and model specification in a retrospective paid claims analysis

    Page :131-132

    J.S. McCombs, D. Stafkey-Mailey, T. Marshall

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Once-daily extended release quetiapine fumarate (quetiapine xr): Pooled safety data from 3 placebo-controlled monotherapy studies in acute schizophrenia

    Page :132-132

    D. Meulien, M. Brecher, K. Huizar

    
  • ·Identifying schizophrenic psychoses with psychological scales - the northern Finland 1966 birth cohort

    Page :132-132

    J. Miettunen, J. Veijola, M.K. Isohanni, T. Paunio, N. Freimer, E. Jaaskelainen, J. Ekelund, L. Peltonen, M. Joukamaa, D. Lichtermann

    
  • ·Prevalence of psychotic symptoms in the general population of the Czech Republic

    Page :132-133

    P. Mohr, L. Csemy, M. Rodriguez, J. Cermak, R. Kawaciukova, D. Seifertova

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Differences between schizophrenic patients with good and poor insight: Clinical correlates and outcome

    Page :133-133

    T. Mongini, F. Castagna, C. Mingrone, L. Pulvirenti, P. Rocca

    
  • ·Comorbidity in schizophrenia

    Page :133-133

    M. Negueruela Lopez, R. Navarro Jimenez, D. Zambrano-Enriquez Gandolfo, E. Fernando Di Stasio, M. Martinez Vigo, I. Basurte Villamor, F.J. Quintero Gutierrez del Alamo, J. Sevilla Vicente, J.L. Gonzalez de Rivera, E. Baca Garcia

    
  • ·Prospective, multicenter, open-label, observational study of sexual function in patients beginning aripiprazole treatment

    Page :133-134

    A.L. Montejo, M.C. Campos, C. Fombellida, M. Franco, J. Garcia Mellado, A. Perez Urnaiz, J.M. Olivares, M.A. Ortega, N. Prieto, Y. Riesgo, I. Barber⁷

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Day treatment program for schizophrenia based on psychoeducation: The 6-week follow-up focused on psychopathology and quality of life

    Page :134-134

    L. Motlova, E. Dragomirecka, J. Cermak, F. Spaniel

    
  • ·Efficacy of integrated neurocognitive and social cognitive group therapy for schizophrenia patients: Results of a randomised controlled multi-centre study

    Page :134-134

    D.R. Mueller, M. Laechler, V. Roder

    
  • ·The niacin skin flush test in schizophrenia- a combined approach using laser doppler flowmetry and a visual rating scale

    Page :134-135

    A. Must, S. Horvath, G. Szekeres, A. Juhasz, Z. Janka

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Gender differences in involuntary treated patients with schizophrenia

    Page :135-135

    A. Nawka, J. Raboch, L. Nawkova, E. Kitzlerova, L. Kalisova, M. Cerny, L. Cihal, T.W. Kallert

    
  • ·Aberrant brain stem function in schizophrenia

    Page :135-135

    S. Nielzén, O. Olsson, J. Källstrand, S. Nehlstedt

    
  • ·Optimized mismatch negativity reflects deficits in schizophrenia patients in a combined EEG and MEG study

    Page :135-135

    H. Thoennessen, M. Zvyagintsev, K.C. Harke, F. Boers, J. Dammers, K. Mathiak, C.H. Norra

    
  • ·Increasing cardiovascular mortality trends in schizophrenia in Sweden

    Page :135-136

    U. Osby, L. Alfredsson, G. Edman, J. Reutfors, G. Isacsson, C. Hennekens, P. Sparen

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Quantitative EEG in three pharmacological models of psychosis

    Page :136-136

    T. Palenicek, M. Fujakova, M. Kutova, M. Brunovsky, V. Bubenikova-Valesova, J. Horacek

    
  • ·Serum lipid levels in schizophrenia and bipolar disorder relapse

    Page :136-136

    D. Kontis, R.M. Psaras, S. Papadopoulos, E. Lia, G. Papageorgiou, S. Teperidis, C. Karouzos

    
  • ·Plasma antioxidants in schizophrenia and manic relapse

    Page :136-137

    D. Kontis, R.M. Psaras, E. Lia, S. Papadopoulos, E. Baka, S. Makri, C. Karouzos

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Use of functional rating scales in clinical practice

    Page :137-137

    E. Papathomas, R. Anagnosti

    
  • ·Comparative efficacy and tolerability of intramuscular/oral ziprasidone versus haloperidol: Clinical findings in Asian and foreign patients with acute schizophrenia

    Page :137-137

    B. Parsons, C. Siu, G. Cohen

    
  • ·Factors that influence duration of hospital treatment of psychotic patients

    Page :137-137

    A.M. Petrovic, N.S. Djokic, D.V. Vukic

    
  • ·Social skills and neurocognitive individualized training in patients with schizophrenia

    Page :137-138

    G. Piegari, S. Galderisi, A. Mucci, A. Acerra, L. Luciano, F. Santucci, M. Volpe, A. Valente, A.F. Rabasca, P. Mastantuono, M. Maj

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Profile of patients under involuntary outpatient treatment in the province of Gipuzkoa (Basque Country, Spain)

    Page :138-138

    B. Piza Vallespir, P. Muela De Blas, M. Salaberria Isasi, S. Holguera Ortiz, C. Liano Sedano, S. Zarrasquin Arizaga, E. Palomo Lerchundi

    
  • ·Memory impairments in first episode schizophrenia and their relationship to the duration of untreated psychosis

    Page :138-138

    C. Popescu, I. Miclutia, I. Craciun, R. Macrea

    
  • ·Report of schizophrenic patient who had inserted continiously several needles in various parts of his body

    Page :138-138

    F. Pouya, A.G. Nejad

     
  • ·Combined application of psychotropic drugs in schizoaffective disorder

    Page :138-139

    J. Radics

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Pellagra psycosis: Clinical case and revision

    Page :139-139

    A.N. Ramos, P. Cintra, P. Varandas

    
  • ·A simulation model to estimate the coronary heart disease risk in schizophrenic patients treated with second-generation-antipsychotic drugs: A Spanish perspective

    Page :139-139

    J. Darba, G. Restovic, J. Bobes, C. Arango, J. Rejas

    
  • ·Yalom's therapheutic factors in the long-term, psychodynamic, outpatient group psychotherapy with psychotic patients

    Page :139-140

    B. Restek-Petrovic, A. Bogovic, M. Grah, M. Mihanovic

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Early intervention in psychosis: A comprehensive hospital outpatient programme for the first episodes during the critical period of illness

    Page :140-140

    B. Restek-Petrovic, M. Mihanovic, M. Grah, A. Bogovic, S. Molnar, V. Grosic, S. Kezic

    
  • ·Evaluation of basic symptoms in schizophrenia in Iran, Ardabil

    Page :140-140

    P. Molavi, E. Rezaei Ghalechi

    
  • ·Follow and study basic symptoms & problems in schizophrenia patients in north west of Iran

    Page :140-140

    P. Molavi, H. Ghamari Ghivi, E. Rezaei Ghale Chi, R. Arab

    
  • ·The incidence of risk factors for metabolic syndrome in patients with mental illness

    Page :140-141

    N. Robins, M. Selvaraj, J. Scaria

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·An audit of antipsychotic depot: Patients' perspective

    Page :141-141

    N.M. Robins, M. Selvaraj, J. Scaria

    
  • ·Empirical evidence of residential skills therapy for schizophrenic patients: A controlled study including a 5-year follow-up

    Page :141-141

    V. Roder, D.R. Mueller, U. Keppeler

    
  • ·Characteristics of patients at first contact for psychosis in Bologna

    Page :141-142

    E. Rossi, D. Pecile, E. Mori, N. Cevenini, R. Michetti, D. Berardi

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Comorbidity of substance abuse and early psychosis in Bologna

    Page :142-142

    E. Mori, E. Rossi, D. Pecile, N. Cevenini, R. Michetti, D. Berardi

    
  • ·Neurocognitive functions as endophenotypes in schizophrenia and bipolar disorder

    Page :142-142

    G.M. Sachs, O. Pintsov, B. Winklbaur, A. Erfurth, G. Lenz, K. Thau

    
  • ·Toxic abuse and therapeutic non-fulfilment of psychotic disorders

    Page :142-142

    C. Salazar, M.D. Ortega, C. Martinez, M.R. Gomez, L. León

    
  • ·Correlation of lipid peroxidation, total antioxidant capacity and thiol groups in schizophrenia and normal subjects

    Page :142-143

    B. Salehi, K. Vakilian, A. Rangbar

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Vocational rehabilitation for schizophrenic patients in Germany: Is it cost-effective in the long run?

    Page :143-143

    H.J. Salize

    
  • ·Incidence of schizophrenia is not declining in Finland - any more

    Page :143-143

    R.K.R. Salokangas, M. Helminen, A.M. Koivisto, H. Rantanen, H. Oja, S. Pirkola, K. Wahbeck, M. Joukamaa

    
  • ·Sexual dysfunction and quality of life in schizophrenia

    Page :143-144

    H. Salvan, R. Macrea

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Dissociation in patients with schizophrenia: Relationships with childhood trauma and psychotic symptoms

    Page :144-144

    I. Schafer, B. Reitemeier, L. Langer, V. Aderhold, T. Harfst

    
  • ·Magnetic resonance imaging of the frontal lobe in twins with schizophrenia

    Page :144-144

    A. Schmechtig, M. Picchioni, U. Ettinger, V. Kumari, K. Matsumoto, N. Van Haren, N. Marshall, M. Hall, K. Schulze, T. Toulopoulou, N. Davies, T. Ribchester, S. Williams, P. McGuire, R. Murray

    
  • ·Co-occurrance of childhood trauma and adult psychosis: A picture of co-morbidity

    Page :144-144

    A. Schneeberger, K. Muenzenmaier, D. Castille, B. Link

    
  • ·Early cognitive response to treatment in first episode psychosis

    Page :144-145

    R. Schoeman, B. Chiliza, R. Emsley

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Strategies for switching from amisulpride to ziprasidone in chronics outpatients with schizoprenia or schizoaffective disorders

    Page :145-145

    D. Sechter, E. Haffen, V. Millet

    
  • ·Remission in patients with psychotic disorder and treatment with risperidone of long liberation

    Page :145-145

    M. Serrano Vazquez, M.C. Serrano Carton, M.M. Serrano Carton

    
  • ·Guidelines on use of antipsychotic medication in schizophrenia in a group of acute hospitalary units in first and sucessive admission

    Page :145-146

    M. Serrano Vazquez, M.C. Serrano Carton, M.M. Serrano Carton, M. Paramo Fernandez, G. Iglesias Lorenzo, A. Barroso Canizares, I. Lozano Olmos, F. Romero Rubiales

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Delusional beliefs among subjects with schizophrenia, their healthy relatives, and normal subjects

    Page :146-146

    V. Sharifi, N. Yaghoubpour Yekani, M. Mohammadi, H. Amini

    
  • ·Duration of untreated psychosis and pathways to care in patients with first episode psychosis in Iran

    Page :146-146

    V. Sharifi, T. Kermani-Ranjabar, H. Amini, J. Alaghband-rad, N. Salesian, A. Seddigh

    
  • ·Psychotic-like experiences in general population: Prevalence and correlates in an urban dwelling population in Iran

    Page :146-147

    V. Sharifi, L. Faghih Nasiri, Z. Sadeghianmehr, S. Mirkia, Z. Hatmi, S. Darbooy, M. Effatpanah, M. Mirsharifa

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Reducing duration of untreated psychosis (DUP) within early intervention services: Potential and pitfalls

    Page :147-147

    S.P. Singh

    
  • ·Acute and transient psychotic disorders: Do ICD-10 criteria identify a distinct category?

    Page :147-147

    S.P. Singh

    Plan Plan
  • ·Acute and transient psychotic disorders: Precursors, epidemiology, course and outcome

    Page :147-148

    S.P. Singh, T. Burns, S. Amin, P.B. Jones, G.L. Harrison

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Negative symptoms and quality of life: A randomized, 196-week, double-blind study of ziprasidone versus haloperidol

    Page :148-148

    S. Stahl, A. Loebel, A. Malla, J. Newcomer, E. Watsky, P. Harvey, P. Weiden, C. Siu, S. Romano

    
  • ·Tobacco abuse in patients with schizophrenia-first generation vs. second generation antipsychotics treated patients: Results of the clinical study

    Page :148-148

    R. Softic, A. Sutovic

    
  • ·ITAREPS: Information technology aided relapse prevention programme in schizophrenia. A two-year mirror design follow up evaluation

    Page :148-148

    F. Spaniel, J. Hrdlicka, T. Novak, L. Motlova, C. Hoschl

    
  • ·A comparison of treatment-emergent diabetes among atypical and typical antipsychotic users

    Page :148-149

    D.R. Stafkey-Mailey, J.S. McCombs, J.W. Hay

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·The first Croatian outpatient rehabilitation center in psychiatric hospital Vrapce

    Page :149-149

    S. Ivezić, P. El Hassan, P. Jelacic, V. Deus, A. Muzek, N. Kudrić

    
  • ·Assessment of coping strategies in schizophrenia patients in refer to psychiatry clinics of Tehran in 2007

    Page :149-149

    F. Ranjbar, Z. Tamizi, F. Yaghmaie, H. Alavi Majd

    
  • ·Time to discontinuation of olanzapine and risperidone as a measure of effectiveness in a clinical setting

    Page :149-150

    A. Tapp, N. Kilzieh

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Co-therapeutic team as the integrative constituent of group psychotherapy for patients with psychosis on acute psychiatric ward

    Page :150-150

    Z. Terenyi, A. Varga, Z. Jaki, K. Szoke, G. Pal, S.K. Csoligne

    
  • ·Involvement of neurotrophic factors in the treatment of schizophrenia with negative symptoms

    Page :150-150

    A. Tiugan, C. Radut

    
  • ·Patients preference of olanzapine orodispersible tablet compared with olanzapine conventional oral tablet in a multinational, randomized, crossover study

    Page :150-151

    E.M. Ciorabai, I. Oyffe, N. Dilbaz, S. Lozano, S. Ruschel, J. Salburg, Y. Dyachkova, T. Treuer

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·"Before" and "Beyond" the parallelism between phenomenology and neuropsychology

    Page :151-151

    H. Tsuda

    
  • ·Insight in psychosis: Factors involved

    Page :151-151

    I. Vanelli, E. Torre, P. Levy

    
  • ·Coping mechanisms evaluation in chronic schizophrenic patients

    Page :151-151

    D. Vasile, O. Vasiliu, M. Vasile, M. Terpan, I. Paraico

    
  • ·Alteration of body image perception as a side event of antipsychotic treatment in schizophrenic patients

    Page :151-152

    D. Vasile, O. Vasiliu, P. Ivanov, M. Terpan, I. Paraico

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Expression of NR1 subunit of NMDA receptor in schizophrenic hippocampus

    Page :152-152

    M. Vrajova, S. Pekova, J. Klaschka, E. Majer, F. Stastny, V. Bubenikova-Valesova

    
  • ·Influence of personality traits on sexual self-perception and sexual functioning in schizophrenic patients

    Page :152-152

    M. Vucic Peitl, D. Ljubicic, V. Peitl, M. Turkovic

    
  • ·QOL of paranoid schyzophrenic patients

    Page :152-153

    D.V. Vukic, N.S. Djokic, A.M. Petrovic

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Bactrim as an adjunctive treatment to toxoplasma-seropositive patients with schizophrenia

    Page :153-153

    H.L. Wang, G.H. Wang, Q.Y. Li, Z.C. Liu

    
  • ·First rank symptoms in schizophrenia: A cognitive examination of three explanatory models

    Page :153-153

    F. Waters, J. Badcock, M. Dragovic, A. Jablensky

    
  • ·Catechol-o-methyltransferase (COMT) is associated with negative symptoms of schizophrenia

    Page :153-153

    Q. Xu, Y. Fan, Y. Wang, Y. Shen

    
  • ·A family case study on schizophrenia and bipolar disorder: Genotype and Cognition

    Page :153-154

    A.M. Zaharie, I. Miclutia, M. Fadgyas Stanculete, E. Ergul, A. Sazci

    Résumé Résumé Plan Plan

• Poster Session I: Schizophrenia and Psychosis

  • ·Geographical tends of mental disorders of the elderly people in lithuania

    Page :154-154

    E. Razgauskas, R. Petrošius, R. Gumbinaitė, U. Bubėnas, A. Valainis

    

• Poster Session I: Neuroleptics and Antipsychotics

  • ·Prescribing practice of risperidone long-acting injection

    Page :154-154

    I. Agell, N. Gupta, C.A. Riley

    
  • ·Does prescribing practice of clozapine affect length of stay in psychiatric in-patient units?

    Page :154-155

    V. Agrawal, I. Agell

    Résumé Résumé Plan Plan

• Poster Session I: Neuroleptics and Antipsychotics

  • ·Similar subjective response and adherence rates for long-acting risperidone and conventional depots

    Page :155-155

    V. Balanza, T. Merino, A. Tatay, J. Lerma, S. Cepeda, L. Laguna, R. Rosales, A. Pastor, C. Knecht, M. Lacruz

    
  • ·Risk factors for partial adherence to parenteral antipsychotics in outpatients with severe mental disorders

    Page :155-155

    V. Balanza, S. Cepeda, L. Laguna, J. Lerma, T. Merino, A. Tatay, A. Pastor, R. Rosales, C. Knecht, M. Lacruz

    
  • ·Prediction of response in 160 patients with schizophrenia, schizoaffective and bipolar disorder after olanzapine or risperidone treatment

    Page :155-156

    S. Bonaccorso, W.V. Bobo, Y. Chen, K. Jayathilake, H.Y. Meltzer

    Résumé Résumé Plan Plan

• Poster Session I: Neuroleptics and Antipsychotics

  • ·Effect of risperidone-induced hyperprolactinemia on bone mineral density in youth

    Page :156-156

    C.A. Calarge, L. Acion, J.A. Schlechte

    
  • ·Aripiprazole in schizophrenic patients

    Page :156-156

    A. Chinchilla, R. Gonzalez, I. Gobernado, M.F. Pando, A. Loureiro, E. Erausquin, M. Martín, M.D. Crespo, M. Vega

    
  • ·Effects of antipsychotics on aggression during acute hospitalization

    Page :156-157

    A. Colasanti, A. Natoli, D. Moliterno, M.C. Mauri

    Résumé Résumé Plan Plan  

• Poster Session I: Neuroleptics and Antipsychotics

  • ·Placebo-controlled clinical trials of new atypical antipsychotics in schizophrenia

    Page :157-157

    P. Czobor, S. Komlosi, I. Bitter

    
  • ·Antipsychotics in psychiatric inpatients: Naturalistic data on first vs. repeated episodes

    Page :157-157

    M. Delic, N. Segrec, U. Groleger

    
  • ·Hospitalizations and compliance among schizophrenic patients in treatment with clozapine

    Page :157-158

    A. Doll, A. Mena, M. Domato

    Résumé Résumé Plan Plan

• Poster Session I: Neuroleptics and Antipsychotics

  • ·Comparative mortality associated with ziprasidone vs. olanzapine in real-world use: The ziprasidone observational study of cardiac outcomes (zodiac)

    Page :158-158

    B.L. Strom, G. Faich, S.M. Eng, R.F. Reynolds, R.B. D'Agostino, J. Ruskin, J.M. Kane

    
  • ·Risperidone and liver function tests in children and adolescents: A short term prospective study

    Page :158-158

    A. Erdogan, N. Atasoy, H. Akkurt, D. Ozturk, E. Karaahmet, I. Yalug, K. Yalug, H. Ankarali, I. Balcioglu

    
  • ·Effect of risperidone long-acting injection on hospitalisation: A mirror image analysis

    Page :158-159

    E. Etuk, S. Cheeroth, P. Chauchan, G. Khan

    Résumé Résumé Plan Plan

• Poster Session I: Neuroleptics and Antipsychotics

  • ·Efficacy and tolerability of quetiapine in the treatment of schizoaffective disorder: A retrospective study

    Page :159-159

    G. Cerveri, L.S. Volonteri, I. Netti, C. Mencacci

    
  • ·Auricular acupuncture experience among dual diagnosis patients: Randomized controlled pilot clinical trial

    Page :159-159

    E. Goldstien, Y. Baruch, Y. Gimelfarb, Z. Natan, S. Elwahidi, E. Kaikov

    
  • ·Metabolic side effects of atypical antipsychotics in early onset schizophrenia: One year follow-up pilot study

    Page :159-159

    J.L. Goeb, S. Marco, A. Duhamel, R. Jardri, G. Kechid, R. Bordet, P. Delion, P. Thomas

    
  • ·Atypical vs. Conventional antipsychotic drugs – effects on quality of life

    Page :159-160

    B.T. Golubovic, S.A. Drezgic-Vukic

    Résumé Résumé Plan Plan

• Poster Session I: Neuroleptics and Antipsychotics

  • ·Acute use of antipsychotics: The issue of dose

    Page :160-160

    U. Groleger, K.B. Strukelj, M. Delic, N. Segrec, V. Novak-Grubic

    
  • ·Quetiapine reduces sib in non-psychotic BPD: A case report

    Page :160-160

    T. Gruettert

    
  • ·Psychiatrists’ attitudes to antipsychotic depot injections (i): Preferences and choice

    Page :160-161

    P.M. Haddad, I.B. Chaudhry, N. Husain, S. McLaughlin, P. Cunningham, A.S. David, M.X. Patel

    Résumé Résumé Plan Plan

• Poster Session I: Neuroleptics and Antipsychotics

  • ·Audit of antipsychotic prescribing in adult services

    Page :161-161

    L. Haygarth, S. Alibone

    
  • ·Olanzapine induced neutropenia : A case report

    Page :161-161

    S. Tanisman, E. Yazici, E. Ozan, N. Aydin, I. Kirpinar

    
  • ·Can quetiapine induce delirium in bipolar disorder?

    Page :161-161

    H.A. Eski, E. Yazici, S. Algul, E. Ozan, I. Kirpinar

    
  • ·Atypical antipsychotic agents in violent schizophrenic patients: Cholesterol, glucose and triglycerides levels

    Page :161-162

    M.I. Krakowski, P. Czobor, F. Tremeaux

    Résumé Résumé Plan Plan

• Poster Session I: Neuroleptics and Antipsychotics

  • ·Tardive dystonia in neuroleptic treated bipolar disorder and treated with clozapine - a case report and review of the literature

    Page :162-162

    Y. Kwan, K. Sim

    
  • ·Remission in patients with schizophrenia treated with risperidone long-acting injection: Results from the e-STAR project in Czech Republic and Slovakia

    Page :162-162

    J. Pečeňák, I. Tůma, M. Povey, A. Lam

    
  • ·Improvements in illness severity and functioning in patients with schizophrenia treated with risperidone long-acting injection in The Netherlands

    Page :162-163

    M. van Kooten, H. Bij de Weg, E. de Groot-Stam, C.L. Mulder, M. Povey, M. Manders, A. Lam, Z. Zhao

    Résumé Résumé Plan Plan

• Poster Session I: Neuroleptics and Antipsychotics

  • ·Patient and physician satisfaction with risperidone long-acting injection: 18-month interim results from the electronic schizophrenia treatment adherence registry in Belgium

    Page :163-163

    J. Peuskens, M. Povey, J. Van der Veken, A. Jacobs, A. Lam

    
  • ·RGH-188, a d3/d2 dopamine receptor antagonist/partial agonist atypical antipsychotic candidate

    Page :163-163

    I. Laszlovszky, B. Kiss, I. Gyertyan, G. Pasztor Meszaros, N. Seneca, E. Schmidt, Z.S. Nemethy, G.Y. Bugovics, K. Saghy, J. Laszy, M. Kapas, G.Y. Nemeth, Z.S. Szombathelyi

    
  • ·Effect of clozapine and its metabolites on the intracellular calcium concentration in cells of isolated rat islets

    Page :163-164

    L. Hao, W. Gaohua, X. Weidong, W. Xiaoping, W. Huiling

    Résumé Résumé Plan Plan

• Poster Session I: Neuroleptics and Antipsychotics

  • ·Prevalence of neuroleptic-induced movement disorders in psychotic patients within peripheral New Zealand mental health services: Ethnic variation

    Page :164-164

    H. Mahmoud, G. Johnson, V. Tawhai

    
  • ·Association of venous thromboembolism and olanzapine

    Page :164-164

    R. Maly, J. Masopust, L. Hosak, A. Urban

    
  • ·Atypical antipsychotics in epilepsy

    Page :164-164

    D. Marcoci, A. Chirita, D. Bondari

    
  • ·Neuroprotective effect of haloperidol, sulpiride, ziprasidone and olanzapine at hippocampal and frontal cortex at rats

    Page :164-165

    D. Marinescu, L. Mogoanta, T. Udristoiu, I. Udristoiu

    Résumé Résumé Plan Plan

• Poster Session I: Neuroleptics and Antipsychotics

  • ·Clozapine in outpatient treatment of patients with non-responsive schizophrenia and depressive symptoms

    Page :165-165

    E. Miceva-Velickoska, N. Manuseva, S. Bajraktarov, V. Calovska-Samardziska

    
  • ·Assessing weight change of risperidone long – acting injectable treatment in dual diagnosis patients

    Page :165-165

    Z. Natan, Y. Gimelfarb, E. Kaikov

    
  • ·Augmenting clozapine with sertindole - A case report

    Page :165-166

    J. Nielsen

    Résumé Résumé Plan Plan

• Poster Session I: Neuroleptics and Antipsychotics

  • ·Sudafed for sertindole-induced decreased ejaculatory volume

    Page :166-166

    J. Nielsen

    
  • ·Off-label use of atypical antipsychotics in the crisis intervention unit: An observational study

    Page :166-166

    B. Novak Sarotar, N. Segrec

    
  • ·Previously untreated patients with schizophrenia : The nnt for all causes of treatment discontinuation and the nnh for weight gain

    Page :166-166

    D. Novick, J.M. Haro, D. Suarez

    
  • ·Maintenance pharmacotherapy of schizophrenia-long acting risperidone

    Page :166-166

    I. Popovic, V. Popovic, M. Petrovic

    
  • ·Identifying patients for treatment with long-acting injectable antipsychotics

    Page :166-167

    R.S.R. Ramachandra

    Résumé Résumé Plan Plan

• Poster Session I: Neuroleptics and Antipsychotics

  • ·Subjective attitude to risperidone long-acting injectable (RLAI): Results from a long-term Italian study in subjects with schizophrenia or schizoaffective disorder

    Page :167-167

    A. Rossi, M.M. Bernareggi, M.G. Giustra

    
  • ·Remission in schizophrenia: 1 year Italian study with risperidone long-acting injectable (RLAI) in subjects with schizophrenia or schizoaffective disorder

    Page :167-167

    A. Rossi, M.M. Bernareggi, M.G. Giustra

    
  • ·Clinical maintenance response with risperidone long-acting injectable (rlai) in subjects with schizophrenia or schizoaffective disorder: A 52 weeks Italian study

    Page :167-168

    A. Rossi, M.M. Bernareggi, M.G. Giustra

    Résumé Résumé Plan Plan

• Poster Session I: Neuroleptics and Antipsychotics

  • ·Effective switch to aripiprazole after amisulpride and ziprasidone induced hyperprolactinemia: A case report

    Page :168-168

    M. Saitis, G. Papazisis, K. Katsigiannopoulos

    
  • ·Comparing the effectiveness of aripiprazole and quetiapine in schizophrenia and psychoses: An independent retrospective study

    Page :168-168

    P. Shajahan, S. Keith, C. Majjiga, J. Murphy, A. MacRae, M. Bashir, M. Taylor

    
  • ·Factors influencing adherence: A patient survey

    Page :168-169

    A. Shoka, A. Manbsingh

    Résumé Résumé Plan Plan

• Poster Session I: Neuroleptics and Antipsychotics

  • ·Atypical antipsychotics and their metabolic impact on psychiatrically hospitalized children and adolescents

    Page :169-169

    R.R. Silva, M. Ghaffari, N. Martinez, E. Teitel, M. Pappagallo, G. Gosselin

    
  • ·Second generation antipsychotic medications induce type 2 diabete like syndrome by increasing hepatic glucose output and subsequently insulin secretion: Implications for mechanism of drug action

    Page :169-169

    G.C. Smith, C. Chaussade, M. Vickers, P.R. Shepherd

    
  • ·First- vs Second-generation antipsychotics in psychotic disorders: Efficacy and tolerability issues

    Page :169-169

    M. Flirski, R. Magierski, T. Sobow, I. Kloszewska

    
  • ·Olanzapine in combination with aripiprazole for treatment of schizophrenia in breast cancer patients

    Page :169-170

    V.V. Sushko

    Résumé Résumé Plan Plan

• Poster Session I: Neuroleptics and Antipsychotics

  • ·Changes in the use of antipsychotics: Longitudinal data

    Page :170-170

    M. Trsinar, V. Novak-Grubic, R. Tavcar, U. Groleger

    
  • ·Clozapine augmentation strategy in schizophrenia

    Page :170-170

    S. Tuinier, W.M. Verhoeven

    
  • ·Subjective experience of schizophrenic patients treated with antipsychotics: Clinical and pharmachological correlates

    Page :170-171

    A. Vita, L. De Peri, A. Rolla, M. Comazzi

    Résumé Résumé Plan Plan

• Poster Session I: Neuroleptics and Antipsychotics

  • ·Must the risk of side effects dictate pharmacological practices?

    Page :171-171

    N. Zdanowicz, M. Agius, G. Taormina

    

• Poster Session I: Biological Markers

  • ·Craving, leptin and metabolic assessment in subjects with cocaine abuse-dependence

    Page :171-171

    S. Andreoli, G. Martinotti, F. Alimonti, G. Autullo, M. Di Nicola, F. Tonioni, L. Janiri

    
  • ·Serotonin receptor 1a, 2a, 2c and CONT SNPs and personality traits in suicide attempters and controls

    Page :171-172

    R. Calati, A. Serretti, I. Giegling, A.M. Hartmann, H.J. Möller, C. Colombo, D. Rujescu

    Résumé Résumé Plan Plan

• Poster Session I: Biological Markers

  • ·Voltammetric determination of neurotransmitters as biochemical markers in psychiatric diseases

    Page :172-172

    A. Ciucu, C. Negulescu, A. Ciobanu, D. Marinescu

    
  • ·Association study for neurocognitive endophenotype and STin2 polymorphism in major depressive disorder

    Page :172-172

    A. Sarosi, G. Balogh, X. Gonda, A. Szekely, K. Hejjas, M. Sasvari-Szekely, G. Faludi

    
  • ·Orexigenic and anorexigenic peptides do not differentiate two types of anorexia nervosa. The preliminary study

    Page :172-173

    M. Janas-Kozik, M. Stachowicz, A. Zajdel, A. Wilczok, K. Krysta, I. Krupka-Matuszczyk, U. Mazurek

    Résumé Résumé Plan Plan

• Poster Session I: Biological Markers

  • ·Animal models: Possible avenue to understanding schizophrenia

    Page :173-173

    L.B. Jones, N. Marmalejo, J. Paez, J.B. Levitt

    
  • ·Neurobiological model of unitary psychosis

    Page :173-173

    M.H. Khan, H.R. Chaudhary, M.G. Butt, Z. Mukhtar, M. Haq, A. Bakar

    
  • ·Empathy and the mirror system: Findings from a novel affective startle study

    Page :173-174

    J. Kinross, V. Kumari, S. Frangou

    Résumé Résumé Plan Plan

• Poster Session I: Biological Markers

  • ·Interaction between health behaviour, mental distress and the polymorphism of the serotonin transporter gene among adolescents in Oslo, Norway

    Page :174-174

    L. Lien, S. Djurovic, M. Thoresen, E. Bjertness, O.A. Andreassen

    
  • ·Psychophysiological markers of the patrimonial dominant

    Page :174-174

    V.O. Ljubavin

    
  • ·Serotonin transporter gene and adverse life events in adult ADHD

    Page :174-174

    L. Mandelli, D.J. Muller, A. Serretti, C.G. DeYoung⁵, V. De luca, T. Sicard, S. Tharmalingam, J. Gallinat, P. Muglia, D. De Ronchi, U. Jain, J.L. Kennedy

     
  • ·Depression trajectories and medication treatment during pregnancy: Impact on neonatal outcomes

    Page :174-175

    S.M. Marcus, H.A. Flynn, J. Lopez, S. McDonough, D. Vazquez

    Résumé Résumé Plan Plan

• Poster Session I: Biological Markers

  • ·Cortisol as predictor in major depression

    Page :175-175

    K. Martiny, M. Lunde, M. Unden, H. Dam, P. Bech

    
  • ·Polyunsaturated fatty acids and depression: Preliminary results of a randomized double blind placebo controlled study

    Page :175-175

    M. Pomponi, S. Lippa, R. Natili, M. Di Nicola, C. Ciciarelli, M. Mazza, C. Villella, S. Andreoli, G. Conte, L. Janiri, P. Bria

    
  • ·Association of 5HTTLPR with factors related to risk of suicide

    Page :175-176

    X. Gonda, J. Lazary, Z. Rihmer, G. Bagdy

    Résumé Résumé Plan Plan

• Poster Session I: Biological Markers

  • ·Biological markers of families of patients with neurotic, stress-related and somatoform disorders

    Page :176-176

    L.A. Ryadovaya

    
  • ·The subclinical thyroid dysfunction: Risk factor for developing the first depressive episode

    Page :176-176

    S. Simic, T.S. Zogovic

    
  • ·Hyperactivity of MB-COMT in schizophrenia and bipolar disease: Genetic, Epigenetic and Translation studies

    Page :176-177

    C.L. Smith, H.M. Abdolmaleky, R. Shafa

    Résumé Résumé Plan Plan

• Poster Session I: Biological Markers

  • ·Biochemical pathways linked to schizophrenia

    Page :177-177

    C.L. Smith, A.D. Bolton, H.M. Abdolmalkey, R. Shafa

    
  • ·The distinct effect of valence and arousal on subjective and objective measurements of emotional regulation

    Page :177-177

    E. Stefanopoulou, S. Argyropoulos, S. Frangou

    
  • ·Ethane as a biomarker of schizophrenia

    Page :177-177

    B.K. Puri, B.M. Ross, I.H. Treasaden

    
  • ·Variations in the serotonin transporter genotype and potential endophenotypes for affective disorder

    Page :177-178

    M. Vinberg, E. Mellerup, P.K. Andersen, B. Bennike, L.V. Kessing

    Résumé Résumé Plan Plan

• Poster Session I: Eating Disorders

  • ·Bulimia among female students in Marrakesh

    Page :178-178

    I. Adali, F. Manoudi, L. Essabiri, R. Chagh, S. Bououda, S. Boutabia, F. Asri, I. Tazi

    
  • ·Personality and psychopathological traits in spanish eating disorder males: A comparative study

    Page :178-178

    Z.P. Aguera, A. Nunez-Navarro, I. Krug, S. Jimenez-Murcia, R. Granero, E. Penelo, A. Karwautz, D. Collier, J. Treasure, F. Fernandez-Aranda

    
  • ·Levels of cytokines (TNF-α & IL-6) and personality in patients with eating disorders

    Page :178-179

    J. Ahrén-Moonga, N. von Blixen, J. Ronnelid

    Résumé Résumé Plan Plan

• Poster Session I: Eating Disorders

  • ·Subthreshold eating disorder in child psychiatry

    Page :179-179

    J. Balazs, J. Gadoros

    
  • ·Temps-a scale in patients after surgery operation because of pathological obesity

    Page :179-179

    A. Borkowska, M. Jaracz, W. Drozdz, M. Tomaszewska, M. Wilkosc, N.K. Surya, S. Dabrowiecki, A. Tretyn, H. Akiskal, R. Junik

    
  • ·Eating attitudes of adolescent females

    Page :179-180

    M. Burgic - Radmanovic, Z. Gavric, D. Strkic

    Résumé Résumé Plan Plan

• Poster Session I: Eating Disorders

  • ·Psychiatric comorbidity with night eating disorder

    Page :180-180

    Y. Cengiz, O.K. Karamustafalioglu, S. Gonenli, B. Ozcelik, B. Bakim

    
  • ·Eating disorders: Twins studies

    Page :180-180

    M.F. Pando, E. Benitez, C. Erausquin, M. Martin, M. Lazaro, A. Chinchilla

    
  • ·Dialectical behaviour therapy for eating disorders: A randomized control trial

    Page :180-180

    C.M. Courbasson, L. Dixon

    
  • ·Families of patients with concurrent eating and substance use disorders: what do they need?

    Page :180-181

    C.M. Courbasson, C. O'Grady

    Résumé Résumé Plan Plan

• Poster Session I: Eating Disorders

  • ·Suicide attempts in bulimia nervosa: Personality, Psychopathological and Genetic correlates

    Page :181-181

    L. Forcano, F. Fernandez-Aranda, E.M. Alvarez-Moya, C.M. Bulik, A. Carracedo, R. Granero, M. Gratacos, S. Jimenez-Murcia, I. Krug, J.M. Mercader, E. Saus, J. Santamaria, X. Estivill

    
  • ·Decision-making and personality in eating disorder patients

    Page :181-181

    I. Garrido, M. Luque, J.B. Navarro, S. Subira

    
  • ·The investigation on eating disorders and related factors in female youths in Chengdu City of China

    Page :181-182

    X.M. Liang, L.T. Guo, K.Z. Liu

    Résumé